402 results on '"B. Holst"'
Search Results
2. Ghrelin
- Author
-
T.D. Müller, R. Nogueiras, M.L. Andermann, Z.B. Andrews, S.D. Anker, J. Argente, R.L. Batterham, S.C. Benoit, C.Y. Bowers, F. Broglio, F.F. Casanueva, D. D'Alessio, I. Depoortere, A. Geliebter, E. Ghigo, P.A. Cole, M. Cowley, D.E. Cummings, A. Dagher, S. Diano, S.L. Dickson, C. Diéguez, R. Granata, H.J. Grill, K. Grove, K.M. Habegger, K. Heppner, M.L. Heiman, L. Holsen, B. Holst, A. Inui, J.O. Jansson, H. Kirchner, M. Korbonits, B. Laferrère, C.W. LeRoux, M. Lopez, S. Morin, M. Nakazato, R. Nass, D. Perez-Tilve, P.T. Pfluger, T.W. Schwartz, R.J. Seeley, M. Sleeman, Y. Sun, L. Sussel, J. Tong, M.O. Thorner, A.J. van der Lely, L.H.T. van der Ploeg, J.M. Zigman, M. Kojima, K. Kangawa, R.G. Smith, T. Horvath, and M.H. Tschöp
- Subjects
Ghrelin ,Growth hormone segretagogue receptor ,Internal medicine ,RC31-1245 - Abstract
Background: The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the endogenous ligand of the growth hormone secretagogue receptor. Increasing evidence supports more complicated and nuanced roles for the hormone, which go beyond the regulation of systemic energy metabolism. Scope of review: In this review, we discuss the diverse biological functions of ghrelin, the regulation of its secretion, and address questions that still remain 15 years after its discovery. Major conclusions: In recent years, ghrelin has been found to have a plethora of central and peripheral actions in distinct areas including learning and memory, gut motility and gastric acid secretion, sleep/wake rhythm, reward seeking behavior, taste sensation and glucose metabolism.
- Published
- 2015
- Full Text
- View/download PDF
3. Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials
- Author
-
Andreas Kofoed, Morten Hylander Møller, Nicolai Haase, Søren Marker, Lars B. Holst, and Anders Perner
- Subjects
Male ,Gastrointestinal bleeding ,medicine.medical_specialty ,Critical Care ,Denmark ,Iceland ,Plasma Substitutes ,Hydroxyethyl starch ,law.invention ,Hydroxyethyl Starch Derivatives ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Intensive care ,medicine ,Humans ,Computer Simulation ,030212 general & internal medicine ,Pantoprazole ,Finland ,Netherlands ,Norway ,business.industry ,Septic shock ,030208 emergency & critical care medicine ,General Medicine ,Middle Aged ,Anti-Ulcer Agents ,medicine.disease ,Shock, Septic ,Intensive care unit ,United Kingdom ,Intensive Care Units ,Anesthesiology and Pain Medicine ,Sample size determination ,Sample Size ,Emergency medicine ,Female ,Isotonic Solutions ,Gastrointestinal Hemorrhage ,business ,medicine.drug - Abstract
Background Randomized clinical trials (RCTs) are occasionally stopped prematurely before reaching their planned sample sizes. It has been suggested that early stopped RCTs are associated with under- and overestimation of the effect estimates. We simulated the effect of hypothetical premature stopping of three large RCTs done in the intensive care unit (ICU) setting. Methods In this post hoc study, we simulated the impact of stopping trials early by calculating mortality effect estimates continuously after the inclusion of each individual patient in three large RCTs, that is the 6S trial on hydroxyethyl starch vs Ringer's acetate in sepsis in ICU, the TRISS trial on lower vs higher haemoglobin threshold for transfusion in septic shock in ICU and the SUP-ICU trial on pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. Results The three trials included a total of 5087 patients; 798 from the 6S trial, 998 from the TRISS trial and 3291 patients from the SUP-ICU trial. The premature mortality effect estimates showed considerable fluctuations until at least 20%-30% of the sample size was included. The premature estimates became stable after inclusion of 205 patients (26% of the final sample size) in the 6S trial, 133 patients(13%) in the TRISS trial and 1926 patients(59%) in the SUP-ICU trial. Conclusions In this post hoc study of three international RCTs within intensive care, we found that the simulated interim mortality effect estimates showed considerable fluctuations until at least 20%-30% of the sample size was included, but remained instable until the final sample sizes had been included. Thus, this study illustrates the necessity for cautious interpretations of prematurely stopped trials.
- Published
- 2020
- Full Text
- View/download PDF
4. Perspectives on weak interactions in complex materials at different length scales
- Author
-
J. Fiedler, K. Berland, J. W. Borchert, R. W. Corkery, A. Eisfeld, D. Gelbwaser-Klimovsky, M. M. Greve, B. Holst, K. Jacobs, M. Krüger, D. F. Parsons, C. Persson, M. Presselt, T. Reisinger, S. Scheel, F. Stienkemeier, M. Tømterud, M. Walter, R. T. Weitz, and J. Zalieckas
- Subjects
Physics ,General Physics and Astronomy ,ddc:530 ,Physical and Theoretical Chemistry - Abstract
Nanocomposite materials consist of nanometer-sized quantum objects such as atoms, molecules, voids or nanoparticles embedded in a host material. These quantum objects can be exploited as a super-structure, which can be designed to create material properties targeted for specific applications. For electromagnetism, such targeted properties include field enhancements around the bandgap of a semiconductor used for solar cells, directional decay in topological insulators, high kinetic inductance in superconducting circuits, and many more. Despite very different application areas, all of these properties are united by the common aim of exploiting collective interaction effects between quantum objects. The literature on the topic spreads over very many different disciplines and scientific communities. In this review, we present a cross-disciplinary overview of different approaches for the creation, analysis and theoretical description of nanocomposites with applications related to electromagnetic properties. publishedVersion
- Published
- 2022
5. Temperature-Dependent Bending Rigidity of AB-Stacked Bilayer Graphene
- Author
-
S. D. Eder, S. K. Hellner, S. Forti, J. M. Nordbotten, J. R. Manson, C. Coletti, and B. Holst
- Subjects
General Physics and Astronomy - Abstract
The change in bending rigidity with temperature κ(T) for 2D materials is highly debated: theoretical works predict both increase and decrease. Here we present measurements of κ(T), for a 2D material: AB-stacked bilayer graphene. We obtain κ(T) from phonon dispersion curves measured with helium atom scattering in the temperature range 320–400 K. We find that the bending rigidity increases with temperature. Assuming a linear dependence over the measured temperature region we obtain κ(T)=[(1.3 ± 0.1) + (0.006 ± 0.001)T/K] eV by fitting the data. We discuss this result in the context of existing predictions and room temperature measurements. publishedVersion
- Published
- 2021
6. Author response for 'Is cross‐section shape a distinct feature in plant fibre identification?'
- Author
-
H. Lukesova and B. Holst
- Subjects
Identification (information) ,Cross section (physics) ,Feature (computer vision) ,business.industry ,Computer science ,Plant fibre ,Pattern recognition ,Artificial intelligence ,business - Published
- 2020
- Full Text
- View/download PDF
7. Effects of shorter versus longer storage time of transfused red blood cells in adult ICU patients: a systematic review with meta-analysis and Trial Sequential Analysis
- Author
-
Pär I. Johansson, Jørn Wetterslev, Sofie Louise Rygård, Andreas Bender Jonsson, Lars B. Holst, Anders Perner, and Martin Bruun Madsen
- Subjects
Adult ,medicine.medical_specialty ,Erythrocytes ,Time Factors ,Blood transfusion ,Critical Care ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,Specimen Handling ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Anesthesiology ,medicine ,Humans ,030212 general & internal medicine ,Adverse effect ,Randomized Controlled Trials as Topic ,business.industry ,Intensive care unit ,Confidence interval ,Clinical trial ,Intensive Care Units ,Relative risk ,Meta-analysis ,Emergency medicine ,Erythrocyte Transfusion ,business - Abstract
Patients in the intensive care unit (ICU) are often transfused with red blood cells (RBC). During storage, the RBCs and storage medium undergo changes, which may have clinical consequences. Several trials now have assessed these consequences, and we reviewed the present evidence on the effects of shorter versus longer storage time of transfused RBCs on outcomes in ICU patients. We conducted a systematic review with meta-analyses and trial sequential analyses (TSA) of randomised clinical trials including adult ICU patients transfused with fresher versus older or standard issue blood. We included seven trials with a total of 18,283 randomised ICU patients; two trials of 7504 patients were judged to have low risk of bias. We observed no effects of fresher versus older blood on death (relative risk 1.04, 95% confidence interval (CI) 0.97–1.11; 7349 patients; TSA-adjusted CI 0.93–1.15), adverse events (1.26, 0.76–2.09; 7332 patients; TSA-adjusted CI 0.16–9.87) or post-transfusion infections (1.07, 0.96–1.20; 7332 patients; TSA-adjusted CI 0.90–1.27). The results were unchanged by including trials with high risk of bias. TSA confirmed the results and the required information size was reached for mortality for a relative risk change of 20%. We may be able to reject a clinically meaningful effect of RBC storage time on mortality in transfused adult ICU patients as our trial sequential analyses reject a 10% relative risk change in death when comparing fresher versus older blood for transfusion.
- Published
- 2018
- Full Text
- View/download PDF
8. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data
- Author
-
Bruce C V Campbell, Charles B L M Majoie, Gregory W Albers, Bijoy K Menon, Nawaf Yassi, Gagan Sharma, Wim H van Zwam, Robert J van Oostenbrugge, Andrew M Demchuk, Francis Guillemin, Philip White, Antoni Dávalos, Aad van der Lugt, Kenneth S Butcher, Aboubaker Cherifi, Henk A Marquering, Geoffrey Cloud, Juan M Macho Fernández, Jeremy Madigan, Catherine Oppenheim, Geoffrey A Donnan, Yvo B W E M Roos, Jai Shankar, Hester Lingsma, Alain Bonafé, Hélène Raoult, María Hernández-Pérez, Aditya Bharatha, Reza Jahan, Olav Jansen, Sébastien Richard, Elad I Levy, Olvert A Berkhemer, Marc Soudant, Lucia Aja, Stephen M Davis, Timo Krings, Marie Tisserand, Luis San Román, Alejandro Tomasello, Debbie Beumer, Scott Brown, David S Liebeskind, Serge Bracard, Keith W Muir, Diederik W J Dippel, Mayank Goyal, Jeffrey L Saver, Tudor G Jovin, Michael D Hill, Peter J Mitchell, Puck SS Fransen, Lucie A van den Berg, Hester F Lingsma, Albert J Yoo, Wouter J Schonewille, Jan Albert Vos, Paul J Nederkoorn, Marieke JH Wermer, Marianne AA van Walderveen, Julie Staals, Jeannette Hofmeijer, Jacques A. van Oostayen, Geert J. Lycklama à Nijeholt, Jelis Boiten, Patrick A. Brouwer, Bart J. Emmer, Sebastiaan F. de Bruijn, Lukas C. van Dijk, Jaap Kappelle, Rob H Lo, Ewoud J. van Dijk, Joost de Vries, Paul L.M. de Kort, Willem Jan J. van Rooij, Jan S.P. van den Berg, Boudewijn A.A.M. van Hasselt, Leo A.M. Aerden, René J. Dallinga, Marieke C. Visser, Joseph C.J. Bot, Patrick C. Vroomen, Omid Eshghi, Tobien H.C.M.L. Schreuder, Roel J.J. Heijboer, Koos Keizer, Alexander V. Tielbeek, Heleen M. den Hertog, Dick G. Gerrits, Renske M. van den Berg-Vos, Giorgos B. Karas, Ewout W. Steyerberg, Zwenneke Flach, Henk A. Marquering, Marieke E.S. Sprengers, Sjoerd F.M. Jenniskens, Ludo F.M. Beenen, René van den Berg, Peter J. Koudstaal, Wim H. van Zwam, Yvo B.W.E.M. Roos, Robert J. van Oostenbrugge, Charles B.L.M. Majoie, Diederik W.J. Dippel, Martin M. Brown, Thomas Liebig, Theo Stijnen, Tommy Andersson, Heinrich Mattle, Nils Wahlgren, Esther van der Heijden, Naziha Ghannouti, Nadine Fleitour, Imke Hooijenga, Corina Puppels, Wilma Pellikaan, Annet Geerling, Annemieke Lindl-Velema, Gina van Vemde, Ans de Ridder, Paut Greebe, José de Bont-Stikkelbroeck, Joke de Meris, Kirsten Janssen, Willy Struijk, Silvan Licher, Nikki Boodt, Adriaan Ros, Esmee Venema, Ilse Slokkers, Raymie-Jayce Ganpat, Maxim Mulder, Nawid Saiedie, Alis Heshmatollah, Stefanie Schipperen, Stefan Vinken, Tiemen van Boxtel, Jeroen Koets, Merel Boers, Emilie Santos, Jordi Borst, Ivo Jansen, Manon Kappelhof, Marit Lucas, Ralph Geuskens, Renan Sales Barros, Roeland Dobbe, Marloes Csizmadia, MD Hill, M Goyal, AM Demchuk, BK Menon, M Eesa, KJ Ryckborst, MR Wright, NR Kamal, L Andersen, PA Randhawa, T Stewart, S Patil, P Minhas, M Almekhlafi, S Mishra, F Clement, T Sajobi, A Shuaib, WJ Montanera, D Roy, FL Silver, TG Jovin, DF Frei, B Sapkota, JL Rempel, J Thornton, D Williams, D Tampieri, AY Poppe, D Dowlatshahi, JH Wong, AP Mitha, S Subramaniam, G Hull, MW Lowerison, M Salluzzi, M Maxwell, S Lacusta, E Drupals, K Armitage, PA Barber, EE Smith, WF Morrish, SB Coutts, C Derdeyn, B Demaerschalk, D Yavagal, R Martin, R Brant, Y Yu, RA Willinsky, A Weill, C Kenney, H Aram, PK Stys, TW Watson, G Klein, D Pearson, P Couillard, A Trivedi, D Singh, E Klourfeld, O Imoukhuede, D Nikneshan, S Blayney, R Reddy, P Choi, M Horton, T Musuka, V Dubuc, TS Field, J Desai, S Adatia, A Alseraya, V Nambiar, R van Dijk, NJ Newcommon, B Schwindt, KS Butcher, T Jeerakathil, B Buck, K Khan, SS Naik, DJ Emery, RJ Owen, TB Kotylak, RA Ashforth, TA Yeo, D McNally, M Siddiqui, M Saqqur, D Hussain, H Kalashyan, A Manosalva, M Kate, L Gioia, S Hasan, A Mohammad, M Muratoglu, A Cullen, P Brennan, A O'Hare, S Looby, D Hyland, S Duff, M McCusker, B Hallinan, S Lee, J McCormack, A Moore, M O'Connor, C Donegan, L Brewer, A Martin, S Murphy, K O'Rourke, S Smyth, P Kelly, T Lynch, T Daly, P O'Brien, A O'Driscoll, M Martin, R Collins, T Coughlan, D McCabe, D O'Neill, M Mulroy, O Lynch, T Walsh, M O'Donnell, T Galvin, J Harbison, P McElwaine, K Mulpeter, C McLoughlin, M Reardon, E Harkin, E Dolan, M Watts, N Cunningham, C Fallon, S Gallagher, P Cotter, M Crowe, R Doyle, I Noone, M Lapierre, VA Coté, S Lanthier, C Odier, A Durocher, J Raymond, N Daneault, Y Deschaintre, B Jankowitz, L Baxendell, L Massaro, C Jackson-Graves, S Decesare, P Porter, K Armbruster, A Adams, J Billigan, J Oakley, A Ducruet, A Jadhav, D-V Giurgiutiu, A Aghaebrahim, V Reddy, M Hammer, M Starr, V Totoraitis, L Wechsler, S Streib, S Rangaraju, D Campbell, M Rocha, D Gulati, T Krings, L Kalman, A Cayley, J Williams, R Wiegner, LK Casaubon, C Jaigobin, JM del Campo, E Elamin, JD Schaafsma, R Agid, R Farb, K ter Brugge, BL Sapkoda, BW Baxter, K Barton, A Knox, A Porter, A Sirelkhatim, T Devlin, C Dellinger, N Pitiyanuvath, J Patterson, J Nichols, S Quarfordt, J Calvert, H Hawk, C Fanale, A Bitner, A Novak, D Huddle, R Bellon, D Loy, J Wagner, I Chang, E Lampe, B Spencer, R Pratt, R Bartt, S Shine, G Dooley, T Nguyen, M Whaley, K McCarthy, J Teitelbaum, W Poon, N Campbell, M Cortes, C Lum, R Shamloul, S Robert, G Stotts, M Shamy, N Steffenhagen, D Blacquiere, M Hogan, M AlHazzaa, G Basir, H Lesiuk, D Iancu, M Santos, H Choe, DC Weisman, K Jonczak, A Blue-Schaller, Q Shah, L MacKenzie, B Klein, K Kulandaivel, O Kozak, DJ Gzesh, LJ Harris, JS Khoury, J Mandzia, D Pelz, S Crann, L Fleming, K Hesser, B Beauchamp, B Amato-Marzialli, M Boulton, P Lopez- Ojeda, M Sharma, S Lownie, R Chan, R Swartz, P Howard, D Golob, D Gladstone, K Boyle, M Boulos, J Hopyan, V Yang, L Da Costa, CA Holmstedt, AS Turk, R Navarro, E Jauch, S Ozark, R Turner, S Phillips, J Shankar, J Jarrett, G Gubitz, W Maloney, R Vandorpe, M Schmidt, J Heidenreich, G Hunter, M Kelly, R Whelan, L Peeling, PA Burns, A Hunter, I Wiggam, E Kerr, M Watt, A Fulton, P Gordon, I Rennie, P Flynn, G Smyth, S O'Leary, N Gentile, G Linares, P McNelis, K Erkmen, P Katz, A Azizi, M Weaver, C Jungreis, S Faro, P Shah, H Reimer, V Kalugdan, G Saposnik, A Bharatha, Y Li, P Kostyrko, T Marotta, W Montanera, D Sarma, D Selchen, J Spears, JH Heo, K Jeong, DJ Kim, BM Kim, YD Kim, D Song, K-J Lee, J Yoo, OY Bang, S Rho, J Lee, P Jeon, KH Kim, J Cha, SJ Kim, S Ryoo, MJ Lee, S-I Sohn, C-H Kim, H-G Ryu, J-H Hong, H-W Chang, C-Y Lee, J Rha, Bruce CV Campbell, Leonid Churilov, Bernard Yan, Richard Dowling, Thomas J Oxley, Teddy Y Wu, Gabriel Silver, Amy McDonald, Rachael McCoy, Timothy J Kleinig, Rebecca Scroop, Helen M Dewey, Marion Simpson, Mark Brooks, Bronwyn Coulton, Martin Krause, Timothy J Harrington, Brendan Steinfort, Kenneth Faulder, Miriam Priglinger, Susan Day, Thanh Phan, Winston Chong, Michael Holt, Ronil V Chandra, Henry Ma, Dennis Young, Kitty Wong, Tissa Wijeratne, Hans Tu, Elizabeth Mackay, Sherisse Celestino, Christopher F Bladin, Poh Sien Loh, Amanda Gilligan, Zofia Ross, Skye Coote, Tanya Frost, Mark W Parsons, Ferdinand Miteff, Christopher R Levi, Timothy Ang, Neil Spratt, Lara Kaauwai, Monica Badve, Henry Rice, Laetitia de Villiers, P. Alan Barber, Ben McGuinness, Ayton Hope, Maurice Moriarty, Patricia Bennett, Andrew Wong, Alan Coulthard, Andrew Lee, Jim Jannes, Deborah Field, Simon Salinas, Elise Cowley, Barry Snow, John Kolbe, Richard Stark, John King, Richard Macdonnell, John Attia, Cate D'Este, Hans-Christoph Diener, Elad I. Levy, Vitor Mendes Pereira, Gregory W. Albers, Christophe Cognard, David J. Cohen, Werner Hacke, Tudor G. Jovin, Heinrich P. Mattle, Raul G. Nogueira, Adnan H. Siddiqui, Dileep R. Yavagal, Rüdiger von Kummer, Wade Smith, Francis Turjman, Scott Hamilton, Richard Chiacchierini, Arun Amar, Nerses Sanossian, Yince Loh, B Baxter, VK Reddy, A Horev, M Star, A Siddiqui, LN Hopkins, K Snyder, R Sawyer, S Hall, V Costalat, C Riquelme, P Machi, E Omer, C Arquizan, I Mourand, M Charif, X Ayrignac, N Menjot de Champfleur, N Leboucq, G Gascou, M Moynier, R du Mesnil de Rochemont, O Singer, J Berkefeld, C Foerch, M Lorenz, W Pfeilschifer, E Hattingen, M Wagner, SJ You, S Lescher, H Braun, S Dehkharghani, SR Belagaje, A Anderson, A Lima, M Obideen, D Haussen, R Dharia, M Frankel, V Patel, K Owada, A Saad, L Amerson, C Horn, S Doppelheuer, K Schindler, DK Lopes, M Chen, R Moftakhar, C Anton, M Smreczak, JS Carpenter, S Boo, A Rai, T Roberts, A Tarabishy, L Gutmann, C Brooks, J Brick, J Domico, G Reimann, K Hinrichs, M Becker, E Heiss, C Selle, A Witteler, S Al-Boutros, M-J Danch, A Ranft, S Rohde, K Burg, C Weimar, V Zegarac, C Hartmann, M Schlamann, S Göricke, A Ringlestein, I Wanke, C Mönninghoff, M Dietzold, R Budzik, T Davis, G Eubank, WJ Hicks, P Pema, N Vora, J Mejilla, M Taylor, W Clark, A Rontal, J Fields, B Peterson, G Nesbit, H Lutsep, H Bozorgchami, R Priest, O Ologuntoye, S Barnwell, A Dogan, K Herrick, C Takahasi, N Beadell, B Brown, S Jamieson, MS Hussain, A Russman, F Hui, D Wisco, K Uchino, Z Khawaja, I Katzan, G Toth, E Cheng-Ching, M Bain, S Man, A Farrag, P George, S John, L Shankar, A Drofa, R Dahlgren, A Bauer, A Itreat, A Taqui, R Cerejo, A Richmond, P Ringleb, M Bendszus, M Möhlenbruch, T Reiff, H Amiri, J Purrucker, C Herweh, M Pham, O Menn, I Ludwig, I Acosta, C Villar, W Morgan, C Sombutmai, F Hellinger, E Allen, M Bellew, R Gandhi, E Bonwit, J Aly, RD Ecker, D Seder, J Morris, M Skaletsky, J Belden, C Baker, LS Connolly, P Papanagiotou, C Roth, A Kastrup, M Politi, F Brunner, M Alexandrou, H Merdivan, C Ramsey, C Given II, S Renfrow, V Deshmukh, K Sasadeusz, F Vincent, JT Thiesing, J Putnam, A Bhatt, A Kansara, D Caceves, T Lowenkopf, L Yanase, J Zurasky, S Dancer, B Freeman, T Scheibe-Mirek, J Robison, J Roll, D Clark, M Rodriguez, B-FM Fitzsimmons, O Zaidat, JR Lynch, M Lazzaro, T Larson, L Padmore, E Das, A Farrow-Schmidt, A Hassan, W Tekle, C Cate, O Jansen, C Cnyrim, F Wodarg, C Wiese, A Binder, C Riedel, A Rohr, N Lang, H Laufs, S Krieter, L Remonda, M Diepers, J Añon, K Nedeltchev, T Kahles, S Biethahn, M Lindner, V Chang, C Gächter, C Esperon, M Guglielmetti, JF Arenillas Lara, M Martínez Galdámez, AI Calleja Sanz, E Cortijo Garcia, P Garcia Bermejo, S Perez, P Mulero Carrillo, E Crespo Vallejo, M Ruiz Piñero, L Lopez Mesonero, FJ Reyes Muñoz, C Brekenfeld, J-H Buhk, A Krützelmann, G Thomalla, B Cheng, C Beck, J Hoppe, E Goebell, B Holst, U Grzyska, G Wortmann, S Starkman, G Duckwiler, R Jahan, N Rao, S Sheth, K Ng, A Noorian, V Szeder, M Nour, M McManus, J Huang, J Tarpley, S Tateshima, N Gonzalez, L Ali, D Liebeskind, J Hinman, M Calderon-Arnulphi, C Liang, J Guzy, S Koch, K DeSousa, G Gordon-Perue, M Elhammady, E Peterson, V Pandey, S Dharmadhikari, P Khandelwal, A Malik, R Pafford, P Gonzalez, K Ramdas, G Andersen, D Damgaard, P Von Weitzel-Mudersbach, C Simonsen, N Ruiz de Morales Ayudarte, M Poulsen, L Sørensen, S Karabegovich, M Hjørringgaard, N Hjort, T Harbo, K Sørensen, E Deshaies, D Padalino, A Swarnkar, JG Latorre, E Elnour, Z El-Zammar, M Villwock, H Farid, A Balgude, L Cross, K Hansen, M Holtmannspötter, D Kondziella, J Hoejgaard, S Taudorf, H Soendergaard, A Wagner, M Cronquist, T Stavngaard, M Cortsen, LH Krarup, T Hyldal, H-P Haring, S Guggenberger, M Hamberger, J Trenkler, M Sonnberger, K Nussbaumer, C Dominger, E Bach, BD Jagadeesan, R Taylor, J Kim, K Shea, R Tummala, H Zacharatos, D Sandhu, M Ezzeddine, A Grande, D Hildebrandt, K Miller, J Scherber, A Hendrickson, M Jumaa, S Zaidi, T Hendrickson, V Snyder, M Killer-Oberpfalzer, J Mutzenbach, F Weymayr, E Broussalis, K Stadler, A Jedlitschka, A Malek, N Mueller-Kronast, P Beck, C Martin, D Summers, J Day, I Bettinger, W Holloway, K Olds, S Arkin, N Akhtar, C Boutwell, S Crandall, M Schwartzman, C Weinstein, B Brion, S Prothmann, J Kleine, K Kreiser, T Boeckh-Behrens, H Poppert, S Wunderlich, ML Koch, V Biberacher, A Huberle, G Gora-Stahlberg, B Knier, T Meindl, D Utpadel-Fischler, M Zech, M Kowarik, C Seifert, B Schwaiger, A Puri, S Hou, A Wakhloo, M Moonis, N Henninger, R Goddeau, F Massari, A Minaeian, JD Lozano, M Ramzan, C Stout, A Patel, A Tunguturi, S Onteddu, R Carandang, M Howk, M Ribó, E Sanjuan, M Rubiera, J Pagola, A Flores, M Muchada, P Meler, E Huerga, S Gelabert, P Coscojuela, A Tomasello, D Rodriguez, E Santamarina, O Maisterra, S Boned, L Seró, A Rovira, CA Molina, M Millán, L Muñoz, N Pérez de la Ossa, M Gomis, L Dorado, E López-Cancio, E Palomeras, J Munuera, P García Bermejo, S Remollo, C Castaño, R García-Sort, P Cuadras, P Puyalto, M Hernández-Pérez, M Jiménez, A Martínez-Piñeiro, G Lucente, A Dávalos, A Chamorro, X Urra, V Obach, A Cervera, S Amaro, L Llull, J Codas, M Balasa, J Navarro, H Ariño, A Aceituno, S Rudilosso, A Renu, JM Macho, L San Roman, J Blasco, A López, N Macías, P Cardona, H Quesada, F Rubio, L Cano, B Lara, MA de Miquel, L Aja, J Serena, E Cobo, Kennedy R Lees, J Arenillas, R Roberts, F Al-Ajlan, L Zimmel, S Patel, J Martí-Fàbregas, M Salvat-Plana, S Bracard, Xavier Ducrocq, René Anxionnat, Pierre-Alexandre Baillot, Charlotte Barbier, Anne-Laure Derelle, Jean-Christophe Lacour, Yves Samson, Nader Sourour, Flore Baronnet-Chauvet, Frédéric Clarencon, Sophie Crozier, Sandrine Deltour, Federico Di Maria, Raphael Le Bouc, Anne Leger, Gurkan Mutlu, Charlotte Rosso, Zoltan Szatmary, Marion Yger, Chiara Zavanone, Serge Bakchine, Laurent Pierot, Nathalie Caucheteux, Laurent Estrade, Krzysztof Kadziolka, Alexandre Leautaud, Céline Renkes, Isabelle Serre, Hubert Desal, Benoît Guillon, Claire Boutoleau-Bretonniere, Benjamin Daumas-Duport, Solène De Gaalon, Pascal Derkinderen, Sarah Evain, Fanny Herisson, David-Axel Laplaud, Thibaud Lebouvier, Alina Lintia-Gaultier, Hélène Pouclet-Courtemanche, Tiphaine Rouaud, Violaine Rouaud Jaffrenou, Aurélia Schunck, Mathieu Sevin-Allouet, Frederique Toulgoat, Sandrine Wiertlewski, Jean-Yves Gauvrit, Thomas Ronziere, Vincent Cahagne, Jean-Christophe Ferre, Jean-François Pinel, Jean-Louis Mas, Jean-François Meder, Amen-Adam Al Najjar-Carpentier, Julia Birchenall, Eric Bodiguel, David Calvet, Valérie Domigo, Sylvie Godon-Hardy, Vincent Guiraud, Catherine Lamy, Loubna Majhadi, Ludovic Morin, Olivier Naggara, Denis Trystram, Guillaume Turc, Jérôme Berge, Igor Sibon, Patrice Menegon, Xavier Barreau, François Rouanet, Sabrina Debruxelles, Annabelle Kazadi, Pauline Renou, Olivier Fleury, Anne Pasco-Papon, Frédéric Dubas, Jildaz Caroff, Sophie Godard Ducceschi, Marie-Aurélie Hamon, Alderic Lecluse, Guillaume Marc, Maurice Giroud, Frédéric Ricolfi, Yannick Bejot, Adrien Chavent, Arnaud Gentil, Apolline Kazemi, Guy-Victor Osseby, Charlotte Voguet, Marie-Hélène Mahagne, Jacques Sedat, Yves Chau, Laurent Suissa, Sylvain Lachaud, Emmanuel Houdart, Christian Stapf, Frédérique Buffon Porcher, Hugues Chabriat, Pierre Guedin, Dominique Herve, Eric Jouvent, Jérôme Mawet, Jean-Pierre Saint-Maurice, Hans-Martin Schneble, Norbert Nighoghossian, Nadia-Nawel Berhoune, Françoise Bouhour, Tae-Hee Cho, Laurent Derex, Sandra Felix, Hélène Gervais-Bernard, Benjamin Gory, Luis Manera, Laura Mechtouff, Thomas Ritzenthaler, Roberto Riva, Fabrizio Salaris Silvio, Caroline Tilikete, Raphael Blanc, Michaël Obadia, Mario Bruno Bartolini, Antoine Gueguen, Michel Piotin, Silvia Pistocchi, Hocine Redjem, Jacques Drouineau, Jean-Philippe Neau, Gaelle Godeneche, Matthias Lamy, Emilia Marsac, Stephane Velasco, Pierre Clavelou, Emmanuel Chabert, Nathalie Bourgois, Catherine Cornut-Chauvinc, Anna Ferrier, Jean Gabrillargues, Betty Jean, Anna-Raquel Marques, Nicolas Vitello, Olivier Detante, Marianne Barbieux, Kamel Boubagra, Isabelle Favre Wiki, Katia Garambois, Florence Tahon, Vasdev Ashok, Oguzhan Coskun, Georges Rodesch, Bertrand Lapergue, Frédéric Bourdain, Serge Evrard, Philippe Graveleau, Jean Pierre Decroix, Adrien Wang, François Sellal, Guido Ahle, Gabriela Carelli, Marie-Hélène Dugay, Claude Gaultier, Ariel Pablo Lebedinsky, Lavinia Lita, Raul Mariano Musacchio, Catherine Renglewicz-Destuynder, Alain Tournade, Françis Vuillemet, Francisco Macian Montoro, Charbel Mounayer, Frederic Faugeras, Laetitia Gimenez, Catherine Labach, Géraldine Lautrette, Christian Denier, Guillaume Saliou, Olivier Chassin, Claire Dussaule, Elsa Melki, Augustin Ozanne, Francesco Puccinelli, Marina Sachet, Mariana Sarov, Jean-François Bonneville, Thierry Moulin, Alessandra Biondi, Elisabeth De Bustos Medeiros, Fabrice Vuillier, Patrick Courtheoux, Fausto Viader, Marion Apoil-Brissard, Mathieu Bataille, Anne-Laure Bonnet, Julien Cogez, Emmanuel Touze, Xavier Leclerc, Didier Leys, Mohamed Aggour, Pierre Aguettaz, Marie Bodenant, Charlotte Cordonnier, Dominique Deplanque, Marie Girot, Hilde Henon, Erwah Kalsoum, Christian Lucas, Jean-Pierre Pruvo, Paolo Zuniga, Caroline Arquizan, Vincent Costalat, Paolo Machi, Isabelle Mourand, Carlos Riquelme, Pierre Bounolleau, Charles Arteaga, Anthony Faivre, Marc Bintner, Patrice Tournebize, Cyril Charlin, Françoise Darcel, Pascale Gauthier-Lasalarie, Marcia Jeremenko, Servane Mouton, Jean-Baptiste Zerlauth, Chantal Lamy, Deramond Hervé, Hosseini Hassan, André Gaston, Francis-Guy Barral, Pierre Garnier, Rémy Beaujeux, Valérie Wolff, Denis Herbreteau, Séverine Debiais, Alicia Murray, Gary Ford, Andy Clifton, Janet Freeman, Ian Ford, Hugh Markus, Joanna Wardlaw, Andy Molyneux, Thompson Robinson, Steff Lewis, John Norrie, Fergus Robertson, Richard Perry, Anand Dixit, Andrew Clifton, Christine Roffe, Sanjeev Nayak, Kyriakos Lobotesis, Craig Smith, Amit Herwadkar, Naga Kandasamy, Tony Goddard, John Bamford, Ganesh Subramanian, Rob Lenthall, Edward Littleton, Sal Lamin, Kelley Storey, Rita Ghatala, Azra Banaras, John Aeron-Thomas, Bath Hazel, Holly Maguire, Emelda Veraque, Louise Harrison, Rekha Keshvara, James Cunningham, Clinical Neurophysiology, Weimar, Christian (Beitragende*r), Radiology and nuclear medicine, Rheumatology, ACS - Atherosclerosis & ischemic syndromes, RS: Carim - B05 Cerebral small vessel disease, RS: CARIM - R3.03 - Cerebral small vessel disease, RS: Carim - B06 Imaging, Beeldvorming, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: CARIM - R3.11 - Imaging, MUMC+: MA Neurologie (3), Klinische Neurowetenschappen, MUMC+: MA AIOS Neurologie (9), The Royal Melbourne Hospital, Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA), Stanford University, University of Calgary, The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University [Maastricht], Centre d'investigation clinique - Epidémiologie clinique [Nancy] (CIC-EC), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute of Neuroscience [Newcastle] (ION), Newcastle University [Newcastle], Universitat Autònoma de Barcelona (UAB), Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Alberta, Centre d'Investigation Clinique - Innovation Technologique [Nancy] (CIC-IT), Monash University [Melbourne], St George’s University Hospitals, Institut de psychiatrie et neurosciences (U894 / UMS 1266), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Dalhousie University [Halifax], Neuroradiologie [Hôpital Gui de Chauliac], Hôpital Gui de Chauliac [Montpellier], Service de Neuroradiologie [Rennes], CHU Pontchaillou [Rennes], St. Michael's Hospital, University of California [Los Angeles] (UCLA), University of California, University Medical Center of Schleswig–Holstein = Universitätsklinikum Schleswig-Holstein (UKSH), Kiel University, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service de neurologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), University at Buffalo [SUNY] (SUNY Buffalo), State University of New York (SUNY), Toronto Western Hospital, Hôpital Foch [Suresnes], Vall d'Hebron University Hospital [Barcelona], Département de neuroradiologie diagnostique et thérapeutique [CHRU Nancy], Imagerie Adaptative Diagnostique et Interventionnelle (IADI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), University of Glasgow, Queen Elizabeth University Hospital (Glasgow), David Geffen School of Medicine [Los Angeles], University of California-University of California, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Radiology & Nuclear Medicine, Public Health, Neurology, Radiology and Nuclear Medicine, ACS - Microcirculation, ANS - Neurovascular Disorders, ACS - Amsterdam Cardiovascular Sciences, Graduate School, ACS - Pulmonary hypertension & thrombosis, AGEM - Digestive immunity, AGEM - Re-generation and cancer of the digestive system, ARD - Amsterdam Reproduction and Development, Biomedical Engineering and Physics, APH - Personalized Medicine, APH - Quality of Care, and AMS - Restoration & Development
- Subjects
SELECTION ,COMPUTED TOMOGRAPHIC PERFUSION ,Medizin ,Perfusion scanning ,030204 cardiovascular system & hematology ,Brain Ischemia ,0302 clinical medicine ,Modified Rankin Scale ,REPERFUSION ,Stroke ,ComputingMilieux_MISCELLANEOUS ,Thrombectomy ,Aged, 80 and over ,medicine.diagnostic_test ,Penumbra ,Endovascular Procedures ,Brain ,Middle Aged ,Magnetic Resonance Imaging ,3. Good health ,Treatment Outcome ,Cerebral blood flow ,Tissue Plasminogen Activator ,INFARCT ,Cardiology ,Female ,TRIAL ,CT ,medicine.medical_specialty ,Perfusion Imaging ,Neuroimaging ,[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine ,03 medical and health sciences ,Fibrinolytic Agents ,ALTEPLASE ,Internal medicine ,medicine ,[INFO.INFO-IM]Computer Science [cs]/Medical Imaging ,Humans ,Aged ,business.industry ,MECHANICAL THROMBECTOMY ,Other Research Radboud Institute for Health Sciences [Radboudumc 0] ,Magnetic resonance imaging ,Odds ratio ,medicine.disease ,Neurology (clinical) ,business ,Tomography, X-Ray Computed ,030217 neurology & neurosurgery ,Fibrinolytic agent ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Background CT perfusion (CTP) and diffusion or perfusion MRI might assist patient selection for endovascular thrombectomy. We aimed to establish whether imaging assessments of irreversibly injured ischaemic core and potentially salvageable penumbra volumes were associated with functional outcome and whether they interacted with the treatment effect of endovascular thrombectomy on functional outcome.Methods In this systematic review and meta-analysis, the HERMES collaboration pooled patient-level data from all randomised controlled trials that compared endovascular thrombectomy (predominantly using stent retrievers) with standard medical therapy in patients with anterior circulation ischaemic stroke, published in PubMed from Jan 1,2010, to May 31, 2017. The primary endpoint was functional outcome, assessed by the modified Rankin Scale (mRS) at 90 days after stroke. Ischaemic core was estimated, before treatment with either endovascular thrombectomy or standard medical therapy, by CTP as relative cerebral blood flow less than 30% of normal brain blood flow or by MRI as an apparent diffusion coefficient less than 620 mu m(2)/s. Critically hypoperfused tissue was estimated as the volume of tissue with a CTP time to maximum longer than 6 s. Mismatch volume (ie, the estimated penumbral volume) was calculated as critically hypoperfused tissue volume minus ischaemic core volume. The association of ischaemic core and penumbral volumes with 90-day mRS score was analysed with multivariable logistic regression (functional independence, defined as mRS score 0-2) and ordinal logistic regression (functional improvement by at least one mRS category) in all patients and in a subset of those with more than 50% endovascular reperfusion, adjusted for baseline prognostic variables. The meta-analysis was prospectively designed by the HERMES executive committee, but not registered.Findings We identified seven studies with 1764 patients, all of which were included in the meta-analysis. CTP was available and assessable for 591 (34%) patients and diffusion MRI for 309 (18%) patients. Functional independence was worse in patients who had CTP versus those who had diffusion MRI, after adjustment for ischaemic core volume (odds ratio [OR] 0.47 [95% CI 0.30-0.72], p=0.0007), so the imaging modalities were not pooled. Increasing ischaemic core volume was associated with reduced likelihood of functional independence (CTP OR 0.77 [0.69-0.86] per 10 mL, p(interaction)=0.29; diffusion MRI OR 0.87 [0.81-0.94] per 10 mL, p(interaction)=0.94). Mismatch volume, examined only in the CTP group because of the small numbers of patients who had perfusion MRI, was not associated with either functional independence or functional improvement. In patients with CTP with more than 50% endovascular reperfusion (n=186), age, ischaemic core volume, and imaging-to-reperfusion time were independently associated with functional improvement. Risk of bias between studies was generally low.Interpretation Estimated ischaemic core volume was independently associated with functional independence and functional improvement but did not modify the treatment benefit of endovascular thrombectomy over standard medical therapy for improved functional outcome. Combining ischaemic core volume with age and expected imagingto-reperfusion time will improve assessment of prognosis and might inform endovascular thrombectomy treatment decisions. Copyright (C) 2018 Elsevier Ltd. All rights reserved.
- Published
- 2019
- Full Text
- View/download PDF
9. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial
- Author
-
Lars B. Holst, Sari Karlsson, Anders Perner, Anne Berit Guttormsen, Jan Wernerman, Per Winkel, Jørn Wetterslev, Sofie Louise Rygård, and Pär I. Johansson
- Subjects
Male ,Risk ,medicine.medical_specialty ,Time Factors ,Population ,Critical Care and Intensive Care Medicine ,law.invention ,Hemoglobins ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,law ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,education ,Aged ,education.field_of_study ,Septic shock ,business.industry ,Mortality rate ,Hazard ratio ,Anemia ,030208 emergency & critical care medicine ,Middle Aged ,medicine.disease ,Shock, Septic ,Intensive care unit ,Confidence interval ,Surgery ,Intensive Care Units ,Relative risk ,Quality of Life ,Female ,Erythrocyte Transfusion ,business ,Follow-Up Studies - Abstract
We assessed the predefined long-term outcomes in patients randomised in the Transfusion Requirements in Septic Shock (TRISS) trial. In 32 Scandinavian ICUs, we randomised 1005 patients with septic shock and haemoglobin of 9 g/dl or less to receive single units of leuko-reduced red cells when haemoglobin level was 7 g/dl or less (lower threshold) or 9 g/dl or less (higher threshold) during ICU stay. We assessed mortality rates 1 year after randomisation and again in all patients at time of longest follow-up in the intention-to-treat population (n = 998) and health-related quality of life (HRQoL) 1 year after randomisation in the Danish patients only (n = 777). Mortality rates in the lower- versus higher-threshold group at 1 year were 53.5 % (268/501 patients) versus 54.6 % (271/496) [relative risk 0.97; 95 % confidence interval (CI) 0.85–1.09; P = 0.62]; at longest follow-up (median 21 months), they were 56.7 % (284/501) versus 61.0 % (302/495) (hazard ratio 0.88; 95 % CI 0.75–1.03; P = 0.12). We obtained HRQoL data at 1 year in 629 of the 777 (81 %) Danish patients, and mean differences between the lower- and higher-threshold group in scores of physical HRQoL were 0.4 (95 % CI −2.4 to 3.1; P = 0.79) and in mental HRQoL 0.5 (95 % CI −3.1 to 4.0; P = 0.79). Long-term mortality rates and HRQoL did not differ in patients with septic shock and anaemia who were transfused at a haemoglobin threshold of 7 g/dl versus a threshold of 9 g/dl. We may reject a more than 3 % increased hazard of death in the lower- versus higher-threshold group at the time of longest follow-up.
- Published
- 2016
- Full Text
- View/download PDF
10. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
- Author
-
Bruce C V Campbell, Wim H van Zwam, Mayank Goyal, Bijoy K Menon, Diederik W J Dippel, Andrew M Demchuk, Serge Bracard, Philip White, Antoni Dávalos, Charles B L M Majoie, Aad van der Lugt, Gary A Ford, Natalia Pérez de la Ossa, Michael Kelly, Romain Bourcier, Geoffrey A Donnan, Yvo B W E M Roos, Oh Young Bang, Raul G Nogueira, Thomas G Devlin, Lucie A van den Berg, Frédéric Clarençon, Paul Burns, Jeffrey Carpenter, Olvert A Berkhemer, Dileep R Yavagal, Vitor Mendes Pereira, Xavier Ducrocq, Anand Dixit, Helena Quesada, Jonathan Epstein, Stephen M Davis, Olav Jansen, Marta Rubiera, Xabier Urra, Emilien Micard, Hester F Lingsma, Olivier Naggara, Scott Brown, Francis Guillemin, Keith W Muir, Robert J van Oostenbrugge, Jeffrey L Saver, Tudor G Jovin, Michael D Hill, Peter J Mitchell, Puck SS Fransen, Debbie Beumer, Albert J Yoo, Wouter J Schonewille, Jan Albert Vos, Paul J Nederkoorn, Marieke JH Wermer, Marianne AA van Walderveen, Julie Staals, Jeannette Hofmeijer, Jacques A. van Oostayen, Geert J. Lycklama à Nijeholt, Jelis Boiten, Patrick A. Brouwer, Bart J. Emmer, Sebastiaan F. de Bruijn, Lukas C. van Dijk, Jaap Kappelle, Rob H Lo, Ewoud J. van Dijk, Joost de Vries, Paul L.M. de Kort, Willem Jan J. van Rooij, Jan S.P. van den Berg, Boudewijn A.A.M. van Hasselt, Leo A.M. Aerden, René J. Dallinga, Marieke C. Visser, Joseph C.J. Bot, Patrick C. Vroomen, Omid Eshghi, Tobien H.C.M.L. Schreuder, Roel J.J. Heijboer, Koos Keizer, Alexander V. Tielbeek, Heleen M. den Hertog, Dick G. Gerrits, Renske M. van den Berg-Vos, Giorgos B. Karas, Ewout W. Steyerberg, Zwenneke Flach, Henk A. Marquering, Marieke E.S. Sprengers, Sjoerd F.M. Jenniskens, Ludo F.M. Beenen, René van den Berg, Peter J. Koudstaal, Wim H. van Zwam, Yvo B.W.E.M. Roos, Robert J. van Oostenbrugge, Charles B.L.M. Majoie, Diederik W.J. Dippel, Martin M. Brown, Thomas Liebig, Theo Stijnen, Tommy Andersson, Heinrich Mattle, Nils Wahlgren, Esther van der Heijden, Naziha Ghannouti, Nadine Fleitour, Imke Hooijenga, Corina Puppels, Wilma Pellikaan, Annet Geerling, Annemieke Lindl-Velema, Gina van Vemde, Ans de Ridder, Paut Greebe, José de Bont-Stikkelbroeck, Joke de Meris, Kirsten Janssen, Willy Struijk, Silvan Licher, Nikki Boodt, Adriaan Ros, Esmee Venema, Ilse Slokkers, Raymie-Jayce Ganpat, Maxim Mulder, Nawid Saiedie, Alis Heshmatollah, Stefanie Schipperen, Stefan Vinken, Tiemen van Boxtel, Jeroen Koets, Merel Boers, Emilie Santos, Jordi Borst, Ivo Jansen, Manon Kappelhof, Marit Lucas, Ralph Geuskens, Renan Sales Barros, Roeland Dobbe, Marloes Csizmadia, MD Hill, M Goyal, AM Demchuk, BK Menon, M Eesa, KJ Ryckborst, MR Wright, NR Kamal, L Andersen, PA Randhawa, T Stewart, S Patil, P Minhas, M Almekhlafi, S Mishra, F Clement, T Sajobi, A Shuaib, WJ Montanera, D Roy, FL Silver, TG Jovin, DF Frei, B Sapkota, JL Rempel, J Thornton, D Williams, D Tampieri, AY Poppe, D Dowlatshahi, JH Wong, AP Mitha, S Subramaniam, G Hull, MW Lowerison, M Salluzzi, M Maxwell, S Lacusta, E Drupals, K Armitage, PA Barber, EE Smith, WF Morrish, SB Coutts, C Derdeyn, B Demaerschalk, D Yavagal, R Martin, R Brant, Y Yu, RA Willinsky, A Weill, C Kenney, H Aram, PK Stys, TW Watson, G Klein, D Pearson, P Couillard, A Trivedi, D Singh, E Klourfeld, O Imoukhuede, D Nikneshan, S Blayney, R Reddy, P Choi, M Horton, T Musuka, V Dubuc, TS Field, J Desai, S Adatia, A Alseraya, V Nambiar, R van Dijk, NJ Newcommon, B Schwindt, KS Butcher, T Jeerakathil, B Buck, K Khan, SS Naik, DJ Emery, RJ Owen, TB Kotylak, RA Ashforth, TA Yeo, D McNally, M Siddiqui, M Saqqur, D Hussain, H Kalashyan, A Manosalva, M Kate, L Gioia, S Hasan, A Mohammad, M Muratoglu, A Cullen, P Brennan, A O'Hare, S Looby, D Hyland, S Duff, M McCusker, B Hallinan, S Lee, J McCormack, A Moore, M O'Connor, C Donegan, L Brewer, A Martin, S Murphy, K O'Rourke, S Smyth, P Kelly, T Lynch, T Daly, P O'Brien, A O'Driscoll, M Martin, R Collins, T Coughlan, D McCabe, D O'Neill, M Mulroy, O Lynch, T Walsh, M O'Donnell, T Galvin, J Harbison, P McElwaine, K Mulpeter, C McLoughlin, M Reardon, E Harkin, E Dolan, M Watts, N Cunningham, C Fallon, S Gallagher, P Cotter, M Crowe, R Doyle, I Noone, M Lapierre, VA Coté, S Lanthier, C Odier, A Durocher, J Raymond, N Daneault, Y Deschaintre, B Jankowitz, L Baxendell, L Massaro, C Jackson-Graves, S Decesare, P Porter, K Armbruster, A Adams, J Billigan, J Oakley, A Ducruet, A Jadhav, D-V Giurgiutiu, A Aghaebrahim, V Reddy, M Hammer, M Starr, V Totoraitis, L Wechsler, S Streib, S Rangaraju, D Campbell, M Rocha, D Gulati, T Krings, L Kalman, A Cayley, J Williams, R Wiegner, LK Casaubon, C Jaigobin, JM del Campo, E Elamin, JD Schaafsma, R Agid, R Farb, K ter Brugge, BL Sapkoda, BW Baxter, K Barton, A Knox, A Porter, A Sirelkhatim, T Devlin, C Dellinger, N Pitiyanuvath, J Patterson, J Nichols, S Quarfordt, J Calvert, H Hawk, C Fanale, A Bitner, A Novak, D Huddle, R Bellon, D Loy, J Wagner, I Chang, E Lampe, B Spencer, R Pratt, R Bartt, S Shine, G Dooley, T Nguyen, M Whaley, K McCarthy, J Teitelbaum, W Poon, N Campbell, M Cortes, C Lum, R Shamloul, S Robert, G Stotts, M Shamy, N Steffenhagen, D Blacquiere, M Hogan, M AlHazzaa, G Basir, H Lesiuk, D Iancu, M Santos, H Choe, DC Weisman, K Jonczak, A Blue-Schaller, Q Shah, L MacKenzie, B Klein, K Kulandaivel, O Kozak, DJ Gzesh, LJ Harris, JS Khoury, J Mandzia, D Pelz, S Crann, L Fleming, K Hesser, B Beauchamp, B Amato-Marzialli, M Boulton, P Lopez- Ojeda, M Sharma, S Lownie, R Chan, R Swartz, P Howard, D Golob, D Gladstone, K Boyle, M Boulos, J Hopyan, V Yang, L Da Costa, CA Holmstedt, AS Turk, R Navarro, E Jauch, S Ozark, R Turner, S Phillips, J Shankar, J Jarrett, G Gubitz, W Maloney, R Vandorpe, M Schmidt, J Heidenreich, G Hunter, M Kelly, R Whelan, L Peeling, PA Burns, A Hunter, I Wiggam, E Kerr, M Watt, A Fulton, P Gordon, I Rennie, P Flynn, G Smyth, S O'Leary, N Gentile, G Linares, P McNelis, K Erkmen, P Katz, A Azizi, M Weaver, C Jungreis, S Faro, P Shah, H Reimer, V Kalugdan, G Saposnik, A Bharatha, Y Li, P Kostyrko, T Marotta, W Montanera, D Sarma, D Selchen, J Spears, JH Heo, K Jeong, DJ Kim, BM Kim, YD Kim, D Song, K-J Lee, J Yoo, OY Bang, S Rho, J Lee, P Jeon, KH Kim, J Cha, SJ Kim, S Ryoo, MJ Lee, S-I Sohn, C-H Kim, H-G Ryu, J-H Hong, H-W Chang, C-Y Lee, J Rha, Bruce CV Campbell, Leonid Churilov, Bernard Yan, Richard Dowling, Nawaf Yassi, Thomas J Oxley, Teddy Y Wu, Gabriel Silver, Amy McDonald, Rachael McCoy, Timothy J Kleinig, Rebecca Scroop, Helen M Dewey, Marion Simpson, Mark Brooks, Bronwyn Coulton, Martin Krause, Timothy J Harrington, Brendan Steinfort, Kenneth Faulder, Miriam Priglinger, Susan Day, Thanh Phan, Winston Chong, Michael Holt, Ronil V Chandra, Henry Ma, Dennis Young, Kitty Wong, Tissa Wijeratne, Hans Tu, Elizabeth Mackay, Sherisse Celestino, Christopher F Bladin, Poh Sien Loh, Amanda Gilligan, Zofia Ross, Skye Coote, Tanya Frost, Mark W Parsons, Ferdinand Miteff, Christopher R Levi, Timothy Ang, Neil Spratt, Lara Kaauwai, Monica Badve, Henry Rice, Laetitia de Villiers, P. Alan Barber, Ben McGuinness, Ayton Hope, Maurice Moriarty, Patricia Bennett, Andrew Wong, Alan Coulthard, Andrew Lee, Jim Jannes, Deborah Field, Gagan Sharma, Simon Salinas, Elise Cowley, Barry Snow, John Kolbe, Richard Stark, John King, Richard Macdonnell, John Attia, Cate D'Este, Hans-Christoph Diener, Elad I. Levy, Alain Bonafé, Reza Jahan, Gregory W. Albers, Christophe Cognard, David J. Cohen, Werner Hacke, Tudor G. Jovin, Heinrich P. Mattle, Raul G. Nogueira, Adnan H. Siddiqui, Dileep R. Yavagal, Rüdiger von Kummer, Wade Smith, Francis Turjman, Scott Hamilton, Richard Chiacchierini, Arun Amar, Nerses Sanossian, Yince Loh, B Baxter, VK Reddy, A Horev, M Star, A Siddiqui, LN Hopkins, K Snyder, R Sawyer, S Hall, V Costalat, C Riquelme, P Machi, E Omer, C Arquizan, I Mourand, M Charif, X Ayrignac, N Menjot de Champfleur, N Leboucq, G Gascou, M Moynier, R du Mesnil de Rochemont, O Singer, J Berkefeld, C Foerch, M Lorenz, W Pfeilschifer, E Hattingen, M Wagner, SJ You, S Lescher, H Braun, S Dehkharghani, SR Belagaje, A Anderson, A Lima, M Obideen, D Haussen, R Dharia, M Frankel, V Patel, K Owada, A Saad, L Amerson, C Horn, S Doppelheuer, K Schindler, DK Lopes, M Chen, R Moftakhar, C Anton, M Smreczak, JS Carpenter, S Boo, A Rai, T Roberts, A Tarabishy, L Gutmann, C Brooks, J Brick, J Domico, G Reimann, K Hinrichs, M Becker, E Heiss, C Selle, A Witteler, S Al-Boutros, M-J Danch, A Ranft, S Rohde, K Burg, C Weimar, V Zegarac, C Hartmann, M Schlamann, S Göricke, A Ringlestein, I Wanke, C Mönninghoff, M Dietzold, R Budzik, T Davis, G Eubank, WJ Hicks, P Pema, N Vora, J Mejilla, M Taylor, W Clark, A Rontal, J Fields, B Peterson, G Nesbit, H Lutsep, H Bozorgchami, R Priest, O Ologuntoye, S Barnwell, A Dogan, K Herrick, C Takahasi, N Beadell, B Brown, S Jamieson, MS Hussain, A Russman, F Hui, D Wisco, K Uchino, Z Khawaja, I Katzan, G Toth, E Cheng-Ching, M Bain, S Man, A Farrag, P George, S John, L Shankar, A Drofa, R Dahlgren, A Bauer, A Itreat, A Taqui, R Cerejo, A Richmond, P Ringleb, M Bendszus, M Möhlenbruch, T Reiff, H Amiri, J Purrucker, C Herweh, M Pham, O Menn, I Ludwig, I Acosta, C Villar, W Morgan, C Sombutmai, F Hellinger, E Allen, M Bellew, R Gandhi, E Bonwit, J Aly, RD Ecker, D Seder, J Morris, M Skaletsky, J Belden, C Baker, LS Connolly, P Papanagiotou, C Roth, A Kastrup, M Politi, F Brunner, M Alexandrou, H Merdivan, C Ramsey, C Given II, S Renfrow, V Deshmukh, K Sasadeusz, F Vincent, JT Thiesing, J Putnam, A Bhatt, A Kansara, D Caceves, T Lowenkopf, L Yanase, J Zurasky, S Dancer, B Freeman, T Scheibe-Mirek, J Robison, J Roll, D Clark, M Rodriguez, B-FM Fitzsimmons, O Zaidat, JR Lynch, M Lazzaro, T Larson, L Padmore, E Das, A Farrow-Schmidt, A Hassan, W Tekle, C Cate, O Jansen, C Cnyrim, F Wodarg, C Wiese, A Binder, C Riedel, A Rohr, N Lang, H Laufs, S Krieter, L Remonda, M Diepers, J Añon, K Nedeltchev, T Kahles, S Biethahn, M Lindner, V Chang, C Gächter, C Esperon, M Guglielmetti, JF Arenillas Lara, M Martínez Galdámez, AI Calleja Sanz, E Cortijo Garcia, P Garcia Bermejo, S Perez, P Mulero Carrillo, E Crespo Vallejo, M Ruiz Piñero, L Lopez Mesonero, FJ Reyes Muñoz, C Brekenfeld, J-H Buhk, A Krützelmann, G Thomalla, B Cheng, C Beck, J Hoppe, E Goebell, B Holst, U Grzyska, G Wortmann, S Starkman, G Duckwiler, R Jahan, N Rao, S Sheth, K Ng, A Noorian, V Szeder, M Nour, M McManus, J Huang, J Tarpley, S Tateshima, N Gonzalez, L Ali, D Liebeskind, J Hinman, M Calderon-Arnulphi, C Liang, J Guzy, S Koch, K DeSousa, G Gordon-Perue, M Elhammady, E Peterson, V Pandey, S Dharmadhikari, P Khandelwal, A Malik, R Pafford, P Gonzalez, K Ramdas, G Andersen, D Damgaard, P Von Weitzel-Mudersbach, C Simonsen, N Ruiz de Morales Ayudarte, M Poulsen, L Sørensen, S Karabegovich, M Hjørringgaard, N Hjort, T Harbo, K Sørensen, E Deshaies, D Padalino, A Swarnkar, JG Latorre, E Elnour, Z El-Zammar, M Villwock, H Farid, A Balgude, L Cross, K Hansen, M Holtmannspötter, D Kondziella, J Hoejgaard, S Taudorf, H Soendergaard, A Wagner, M Cronquist, T Stavngaard, M Cortsen, LH Krarup, T Hyldal, H-P Haring, S Guggenberger, M Hamberger, J Trenkler, M Sonnberger, K Nussbaumer, C Dominger, E Bach, BD Jagadeesan, R Taylor, J Kim, K Shea, R Tummala, H Zacharatos, D Sandhu, M Ezzeddine, A Grande, D Hildebrandt, K Miller, J Scherber, A Hendrickson, M Jumaa, S Zaidi, T Hendrickson, V Snyder, M Killer-Oberpfalzer, J Mutzenbach, F Weymayr, E Broussalis, K Stadler, A Jedlitschka, A Malek, N Mueller-Kronast, P Beck, C Martin, D Summers, J Day, I Bettinger, W Holloway, K Olds, S Arkin, N Akhtar, C Boutwell, S Crandall, M Schwartzman, C Weinstein, B Brion, S Prothmann, J Kleine, K Kreiser, T Boeckh-Behrens, H Poppert, S Wunderlich, ML Koch, V Biberacher, A Huberle, G Gora-Stahlberg, B Knier, T Meindl, D Utpadel-Fischler, M Zech, M Kowarik, C Seifert, B Schwaiger, A Puri, S Hou, A Wakhloo, M Moonis, N Henninger, R Goddeau, F Massari, A Minaeian, JD Lozano, M Ramzan, C Stout, A Patel, A Tunguturi, S Onteddu, R Carandang, M Howk, M Ribó, E Sanjuan, M Rubiera, J Pagola, A Flores, M Muchada, P Meler, E Huerga, S Gelabert, P Coscojuela, A Tomasello, D Rodriguez, E Santamarina, O Maisterra, S Boned, L Seró, A Rovira, CA Molina, M Millán, L Muñoz, N Pérez de la Ossa, M Gomis, L Dorado, E López-Cancio, E Palomeras, J Munuera, P García Bermejo, S Remollo, C Castaño, R García-Sort, P Cuadras, P Puyalto, M Hernández-Pérez, M Jiménez, A Martínez-Piñeiro, G Lucente, A Dávalos, A Chamorro, X Urra, V Obach, A Cervera, S Amaro, L Llull, J Codas, M Balasa, J Navarro, H Ariño, A Aceituno, S Rudilosso, A Renu, JM Macho, L San Roman, J Blasco, A López, N Macías, P Cardona, H Quesada, F Rubio, L Cano, B Lara, MA de Miquel, L Aja, J Serena, E Cobo, Gregory W Albers, Kennedy R Lees, J Arenillas, R Roberts, F Al-Ajlan, L Zimmel, S Patel, J Martí-Fàbregas, M Salvat-Plana, S Bracard, René Anxionnat, Pierre-Alexandre Baillot, Charlotte Barbier, Anne-Laure Derelle, Jean-Christophe Lacour, Sébastien Richard, Yves Samson, Nader Sourour, Flore Baronnet-Chauvet, Frédéric Clarencon, Sophie Crozier, Sandrine Deltour, Federico Di Maria, Raphael Le Bouc, Anne Leger, Gurkan Mutlu, Charlotte Rosso, Zoltan Szatmary, Marion Yger, Chiara Zavanone, Serge Bakchine, Laurent Pierot, Nathalie Caucheteux, Laurent Estrade, Krzysztof Kadziolka, Alexandre Leautaud, Céline Renkes, Isabelle Serre, Hubert Desal, Benoît Guillon, Claire Boutoleau-Bretonniere, Benjamin Daumas-Duport, Solène De Gaalon, Pascal Derkinderen, Sarah Evain, Fanny Herisson, David-Axel Laplaud, Thibaud Lebouvier, Alina Lintia-Gaultier, Hélène Pouclet-Courtemanche, Tiphaine Rouaud, Violaine Rouaud Jaffrenou, Aurélia Schunck, Mathieu Sevin-Allouet, Frederique Toulgoat, Sandrine Wiertlewski, Jean-Yves Gauvrit, Thomas Ronziere, Vincent Cahagne, Jean-Christophe Ferre, Jean-François Pinel, Hélène Raoult, Jean-Louis Mas, Jean-François Meder, Amen-Adam Al Najjar-Carpentier, Julia Birchenall, Eric Bodiguel, David Calvet, Valérie Domigo, Sylvie Godon-Hardy, Vincent Guiraud, Catherine Lamy, Loubna Majhadi, Ludovic Morin, Denis Trystram, Guillaume Turc, Jérôme Berge, Igor Sibon, Patrice Menegon, Xavier Barreau, François Rouanet, Sabrina Debruxelles, Annabelle Kazadi, Pauline Renou, Olivier Fleury, Anne Pasco-Papon, Frédéric Dubas, Jildaz Caroff, Sophie Godard Ducceschi, Marie-Aurélie Hamon, Alderic Lecluse, Guillaume Marc, Maurice Giroud, Frédéric Ricolfi, Yannick Bejot, Adrien Chavent, Arnaud Gentil, Apolline Kazemi, Guy-Victor Osseby, Charlotte Voguet, Marie-Hélène Mahagne, Jacques Sedat, Yves Chau, Laurent Suissa, Sylvain Lachaud, Emmanuel Houdart, Christian Stapf, Frédérique Buffon Porcher, Hugues Chabriat, Pierre Guedin, Dominique Herve, Eric Jouvent, Jérôme Mawet, Jean-Pierre Saint-Maurice, Hans-Martin Schneble, Norbert Nighoghossian, Nadia-Nawel Berhoune, Françoise Bouhour, Tae-Hee Cho, Laurent Derex, Sandra Felix, Hélène Gervais-Bernard, Benjamin Gory, Luis Manera, Laura Mechtouff, Thomas Ritzenthaler, Roberto Riva, Fabrizio Salaris Silvio, Caroline Tilikete, Raphael Blanc, Michaël Obadia, Mario Bruno Bartolini, Antoine Gueguen, Michel Piotin, Silvia Pistocchi, Hocine Redjem, Jacques Drouineau, Jean-Philippe Neau, Gaelle Godeneche, Matthias Lamy, Emilia Marsac, Stephane Velasco, Pierre Clavelou, Emmanuel Chabert, Nathalie Bourgois, Catherine Cornut-Chauvinc, Anna Ferrier, Jean Gabrillargues, Betty Jean, Anna-Raquel Marques, Nicolas Vitello, Olivier Detante, Marianne Barbieux, Kamel Boubagra, Isabelle Favre Wiki, Katia Garambois, Florence Tahon, Vasdev Ashok, Oguzhan Coskun, Georges Rodesch, Bertrand Lapergue, Frédéric Bourdain, Serge Evrard, Philippe Graveleau, Jean Pierre Decroix, Adrien Wang, François Sellal, Guido Ahle, Gabriela Carelli, Marie-Hélène Dugay, Claude Gaultier, Ariel Pablo Lebedinsky, Lavinia Lita, Raul Mariano Musacchio, Catherine Renglewicz-Destuynder, Alain Tournade, Françis Vuillemet, Francisco Macian Montoro, Charbel Mounayer, Frederic Faugeras, Laetitia Gimenez, Catherine Labach, Géraldine Lautrette, Christian Denier, Guillaume Saliou, Olivier Chassin, Claire Dussaule, Elsa Melki, Augustin Ozanne, Francesco Puccinelli, Marina Sachet, Mariana Sarov, Jean-François Bonneville, Thierry Moulin, Alessandra Biondi, Elisabeth De Bustos Medeiros, Fabrice Vuillier, Patrick Courtheoux, Fausto Viader, Marion Apoil-Brissard, Mathieu Bataille, Anne-Laure Bonnet, Julien Cogez, Emmanuel Touze, Xavier Leclerc, Didier Leys, Mohamed Aggour, Pierre Aguettaz, Marie Bodenant, Charlotte Cordonnier, Dominique Deplanque, Marie Girot, Hilde Henon, Erwah Kalsoum, Christian Lucas, Jean-Pierre Pruvo, Paolo Zuniga, Caroline Arquizan, Vincent Costalat, Paolo Machi, Isabelle Mourand, Carlos Riquelme, Pierre Bounolleau, Charles Arteaga, Anthony Faivre, Marc Bintner, Patrice Tournebize, Cyril Charlin, Françoise Darcel, Pascale Gauthier-Lasalarie, Marcia Jeremenko, Servane Mouton, Jean-Baptiste Zerlauth, Chantal Lamy, Deramond Hervé, Hosseini Hassan, André Gaston, Francis-Guy Barral, Pierre Garnier, Rémy Beaujeux, Valérie Wolff, Denis Herbreteau, Séverine Debiais, Alicia Murray, Gary Ford, Martin M Brown, Andy Clifton, Janet Freeman, Ian Ford, Hugh Markus, Joanna Wardlaw, Andy Molyneux, Thompson Robinson, Steff Lewis, John Norrie, Fergus Robertson, Richard Perry, Geoffrey Cloud, Andrew Clifton, Jeremy Madigan, Christine Roffe, Sanjeev Nayak, Kyriakos Lobotesis, Craig Smith, Amit Herwadkar, Naga Kandasamy, Tony Goddard, John Bamford, Ganesh Subramanian, Rob Lenthall, Edward Littleton, Sal Lamin, Kelley Storey, Rita Ghatala, Azra Banaras, John Aeron-Thomas, Bath Hazel, Holly Maguire, Emelda Veraque, Louise Harrison, Rekha Keshvara, James Cunningham, University of Melbourne, University of Calgary, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Imagerie Adaptative Diagnostique et Interventionnelle (IADI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), University of Amsterdam [Amsterdam] (UvA), Universitat Autònoma de Barcelona (UAB), Département de neuroradiologie diagnostique et thérapeutique [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), ANS - Neurovascular Disorders, Radiology and Nuclear Medicine, ACS - Amsterdam Cardiovascular Sciences, Neurology, Graduate School, Other Research, APH - Personalized Medicine, APH - Quality of Care, Biomedical Engineering and Physics, ARD - Amsterdam Reproduction and Development, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, ACS - Microcirculation, ACS - Atherosclerosis & ischemic syndromes, ACS - Pulmonary hypertension & thrombosis, Radiology & Nuclear Medicine, Public Health, Weimar, Christian (Beitragende*r), Molecular cell biology and Immunology, Pathology, Radiology and nuclear medicine, Amsterdam Neuroscience - Neurovascular Disorders, Rheumatology, Beeldvorming, RS: CARIM - R3.03 - Cerebral small vessel disease, RS: CARIM - R3.11 - Imaging, MUMC+: DA BV Medisch Specialisten Radiologie (9), Klinische Neurowetenschappen, and MUMC+: MA Neurologie (3)
- Subjects
Male ,medicine.medical_specialty ,Sedation ,Medizin ,[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine ,030204 cardiovascular system & hematology ,Anesthesia, General ,CONTROLLED-TRIAL ,THERAPY ,law.invention ,Brain Ischemia ,03 medical and health sciences ,0302 clinical medicine ,All institutes and research themes of the Radboud University Medical Center ,Randomized controlled trial ,law ,Modified Rankin Scale ,Journal Article ,[INFO.INFO-IM]Computer Science [cs]/Medical Imaging ,Medicine ,Humans ,General anaesthesia ,Stroke ,Aged ,Randomized Controlled Trials as Topic ,Thrombectomy ,Aged, 80 and over ,business.industry ,Other Research Radboud Institute for Health Sciences [Radboudumc 0] ,Odds ratio ,MR ,Middle Aged ,Outcome and Process Assessment (Health Care) ,medicine.disease ,Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] ,3. Good health ,Surgery ,Outcome and Process Assessment, Health Care ,Meta-analysis ,Observational study ,Female ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Meta-Analysis - Abstract
BACKGROUND: General anaesthesia (GA) during endovascular thrombectomy has been associated with worse patient outcomes in observational studies compared with patients treated without GA. We assessed functional outcome in ischaemic stroke patients with large vessel anterior circulation occlusion undergoing endovascular thrombectomy under GA, versus thrombectomy not under GA (with or without sedation) versus standard care (ie, no thrombectomy), stratified by the use of GA versus standard care.METHODS: For this meta-analysis, patient-level data were pooled from all patients included in randomised trials in PuMed published between Jan 1, 2010, and May 31, 2017, that compared endovascular thrombectomy predominantly done with stent retrievers with standard care in anterior circulation ischaemic stroke patients (HERMES Collaboration). The primary outcome was functional outcome assessed by ordinal analysis of the modified Rankin scale (mRS) at 90 days in the GA and non-GA subgroups of patients treated with endovascular therapy versus those patients treated with standard care, adjusted for baseline prognostic variables. To account for between-trial variance we used mixed-effects modelling with a random effect for trials incorporated in all models. Bias was assessed using the Cochrane method. The meta-analysis was prospectively designed, but not registered.FINDINGS: Seven trials were identified by our search; of 1764 patients included in these trials, 871 were allocated to endovascular thrombectomy and 893 were assigned standard care. After exclusion of 74 patients (72 did not undergo the procedure and two had missing data on anaesthetic strategy), 236 (30%) of 797 patients who had endovascular procedures were treated under GA. At baseline, patients receiving GA were younger and had a shorter delay between stroke onset and randomisation but they had similar pre-treatment clinical severity compared with patients who did not have GA. Endovascular thrombectomy improved functional outcome at 3 months both in patients who had GA (adjusted common odds ratio (cOR) 1·52, 95% CI 1·09-2·11, p=0·014) and in those who did not have GA (adjusted cOR 2·33, 95% CI 1·75-3·10, pINTERPRETATION: Worse outcomes after endovascular thrombectomy were associated with GA, after adjustment for baseline prognostic variables. These data support avoidance of GA whenever possible. The procedure did, however, remain effective versus standard care in patients treated under GA, indicating that treatment should not be withheld in those who require anaesthesia for medical reasons.FUNDING: Medtronic.
- Published
- 2018
- Full Text
- View/download PDF
11. Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial
- Author
-
Julia S. Johansen, Olivier Chinot, Camilla B. Holst, Mogens K. Boisen, and Nicola Consalvo
- Subjects
0301 basic medicine ,musculoskeletal diseases ,medicine.medical_specialty ,YKL-40 ,AVAglio ,Newly-diagnosed ,Bevacizumab ,bevacizumab ,Placebo ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Proneural Glioblastoma ,Temozolomide ,Proportional hazards model ,business.industry ,Hazard ratio ,glioblastoma ,Confidence interval ,newly-diagnosed ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,Glioblastoma ,business ,medicine.drug ,Research Paper - Abstract
YKL-40 is a glycoprotein with pro-angiogenic functions. We hypothesized that patients with newly diagnosed glioblastoma and low baseline plasma YKL-40 levels derive greater benefit from first-line bevacizumab. Plasma samples were collected from 563 patients in the randomized, phase 3 AVAglio trial who received bevacizumab or placebo plus radiotherapy/temozolomide. Raw plasma YKL-40 concentrations were converted to age-corrected percentiles of normal healthy YKL-40 levels and divided into quartiles (Q). The impact of baseline plasma YKL-40 level on survival was investigated using Cox regression analyses. Patients with low baseline plasma YKL-40 (≤Q1) had an improved progression-free survival hazard ratio (HR) for bevacizumab versus placebo (0.37, 95% confidence interval [CI]: 0.25-0.55) compared with high plasma YKL-40 ( > Q1) (0.71, 95% CI: 0.57-0.87). Overall survival HRs were comparable between the subgroups (≤ Q1: 0.69, 95% CI: 0.44-1.09; (> Q1: 0.88, 95% CI: 0.68-1.13). A trend for improved progression-free survival HR with low versus high YKL-40 was observed in proneural glioblastoma (0.41, 95% CI: 0.13-1.28 vs 0.80, 95% CI: 0.45-1.40, respectively), but not for proliferative/mesenchymal subtypes. Elevated plasma YKL-40 ( > 90th percentile of normal) was an independent negative prognostic factor. In conclusion, the predictive value of baseline plasma YKL-40 level as a biomarker for bevacizumab efficacy in glioblastoma may be limited to patients with proneural tumors. Independent validation studies are required to confirm these results.
- Published
- 2017
- Full Text
- View/download PDF
12. Spontaneous peripartum liver haemorrhage presenting as foetal distress
- Author
-
B. Holst, E. McGuinness, and G. Morris-Stiff
- Subjects
Distress ,medicine.medical_specialty ,Foetal bradycardia ,Perioperative management ,business.industry ,Exploratory laparotomy ,Obstetrics ,medicine.medical_treatment ,Caesarean delivery ,medicine ,Gestation ,business ,Surgery - Abstract
We present the case of a 32-year-old woman who presented at 37 weeks’ gestation with foetal bradycardia. At caesarean delivery, an intra-abdominal haemorrhage was noted before the uterine incision was made. A subsequent exploratory laparotomy revealed the source of the bleeding to be an extensive ruptured haematoma involving both lobes of the liver. Radiologic investigations revealed the presence of multiple cavernous haemangiomata in the liver. The perioperative management of this patient is described, with a brief review of the literature.
- Published
- 2013
- Full Text
- View/download PDF
13. Atomic resolution imaging of beryl: an investigation of the nano-channel occupation
- Author
-
V, Arivazhagan, F D, Schmitz, P E, Vullum, A T J, VAN Helvoort, and B, Holst
- Abstract
Beryl in different varieties (emerald, aquamarine, heliodor etc.) displays a wide range of colours that have fascinated humans throughout history. Beryl is a hexagonal cyclo-silicate (ring-silicate) with channels going through the crystal along the c-axis. The channels are about 0.5 nm in diameter and can be occupied by water and alkali ions. Pure beryl (Be
- Published
- 2016
14. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis
- Author
-
Susan J Brunskill, Timothy S. Walsh, Annemarie B Docherty, Rob O’Donnell, Juliano Pinheiro de Almeida, Martyn J. Parker, Marialena Trivella, Simon J. Stanworth, Carolyn Doree, Merete Gregersen, and Lars B. Holst
- Subjects
Adult ,medicine.medical_specialty ,Acute coronary syndrome ,Blood transfusion ,medicine.medical_treatment ,TRAUMATIC BRAIN-INJURY ,HIP FRACTURE SURGERY ,030204 cardiovascular system & hematology ,law.invention ,CLINICAL-TRIAL ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Blood Transfusion ,030212 general & internal medicine ,Myocardial infarction ,ACUTE-LEUKEMIA ,Acute Coronary Syndrome ,Intensive care medicine ,ELDERLY-PATIENTS ,Randomized Controlled Trials as Topic ,business.industry ,Research ,General Medicine ,medicine.disease ,Confidence interval ,Clinical trial ,Treatment Outcome ,MYOCARDIAL-INFARCTION ,Cardiovascular Diseases ,Meta-analysis ,Relative risk ,Surgical Procedures, Operative ,RANDOMIZED-CONTROLLED-TRIAL ,business ,BLOOD-CELL TRANSFUSION ,CRITICALLY-ILL PATIENTS ,CARDIAC-SURGERY - Abstract
OBJECTIVETo compare patient outcomes of restrictive versus liberal blood transfusion strategies in patients with cardiovascular disease not undergoing cardiac surgery.DESIGNSystematic review and meta-analysis.DATA SOURCESRandomised controlled trials involving a threshold for red blood cell transfusion in hospital. We searched (to 2 November 2015) CENTRAL, Medline, Embase, CINAHL, PubMed, LILACS, NHSBT Transfusion Evidence Library, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ISRCTN Register, and EU Clinical Trials Register. Authors were contacted for data whenever possible.TRIAL SELECTIONPublished and unpublished randomised controlled trials comparing a restrictive with liberal transfusion threshold and that included patients with cardiovascular disease.DATA EXTRACTION AND SYNTHESISData extraction was completed in duplicate. Risk of bias was assessed using Cochrane methods. Relative risk ratios with 95% confidence intervals were presented in all meta-analyses. Mantel-Haenszel random effects models were used to pool risk ratios.MAIN OUTCOME MEASURES30 day mortality, and cardiovascular events.RESULTS41 trials were identified; of these, seven included data on patients with cardiovascular disease. Data from a further four trials enrolling patients with cardiovascular disease were obtained from the authors. In total, 11 trials enrolling patients with cardiovascular disease (n= 3033) were included for meta-analysis (restrictive transfusion, n= 1514 patients; liberal transfusion, n= 1519). The pooled risk ratio for the association between transfusion thresholds and 30 day mortality was 1.15 (95% confidence interval 0.88 to 1.50, P= 0.50), with little heterogeneity (I-2= 14%). The risk of acute coronary syndrome in patients managed with restrictive compared with liberal transfusion was increased (nine trials; risk ratio 1.78, 95% confidence interval 1.18 to 2.70, P= 0.01, I-2= 0%).CONCLUSIONSThe results show that it may not be safe to use a restrictive transfusion threshold of less than 80 g/L in patients with ongoing acute coronary syndrome or chronic cardiovascular disease. Effects on mortality and other outcomes are uncertain. These data support the use of a more liberal transfusion threshold (> 80 g/L) for patients with both acute and chronic cardiovascular disease until adequately powered high quality randomised trials have been undertaken in patients with cardiovascular disease.
- Published
- 2016
- Full Text
- View/download PDF
15. Bildmorphologie der Multiplen Sklerose als inflammatorische und degenerative Erkrankung - Diagnosesicherung und Heterogenität im Krankheitsverlauf
- Author
-
Jens Fiehler, B Holst, and Sven Schippling
- Subjects
medicine.medical_specialty ,Pathology ,Dissemination in time ,medicine.diagnostic_test ,business.industry ,Multiple sclerosis ,Magnetic resonance imaging ,McDonald criteria ,Disease ,Image enhancement ,Clinical routine ,medicine.disease ,Bioinformatics ,Mr imaging ,Neuropsychology and Physiological Psychology ,medicine ,Radiology, Nuclear Medicine and imaging ,Radiology ,Differential diagnosis ,business ,Neuroscience - Abstract
An efficient therapy of MS requires a quick and reliable diagnosis of the disease. MRI is the most leading paraclinical examination for MS diagnosis. Even though there is no pathognomic finding in MRI, there are MS characteristics with respect to morphology and localization. To exclude other neurological disorders and distinguish between different characteristics within MS, the use of contrast agent is advantageous. Postulated MRI criteria have been increasingly adjusted to the clinical routine and have become clearer, more sensitive, and more specific. Different imaging criteria will be introduced. In addition to the McDonald criteria of 2001 and 2005, new criteria will be presented in which the use of contrast agent is replaced by a second MRI and the dissemination in time and space is simplified. Different pathomechanisms which help to separate MS patients into subgroups are postulated. The diverse pathomechanisms also enable the development of new pharmaceuticals to manipulate the immunologic course in different stages. For varying therapy approaches, it is increasingly important to differentiate the heterogeneous appearance forms into subtypes. The two visible main components of the disorder in MRI are inflammation and neurodegeneration and are responsible for different clinical courses. Both are interdependent and independent of each other. We introduce a stratification which uses both components as a function of their different outcomes to compose subgroups. The previous challenge with respect to MRI was to support the diagnosis of MS via MRI criteria. A future problem will be the heterogeneity and classification of subgroups. This article gives an overview of both problems.
- Published
- 2008
- Full Text
- View/download PDF
16. A Giant Reconstruction of α-quartz (0001) Interpreted as Three Domains of Nano Dauphine Twins
- Author
-
S. D. Eder, K. Fladischer, S. R. Yeandel, A. Lelarge, S. C. Parker, E. Søndergård, B. Holst, Surface du Verre et Interfaces (SVI), and Centre National de la Recherche Scientifique (CNRS)
- Subjects
Surfaces ,interfaces and thin films ,Structural properties ,Nano Dauphine Twins ,Electronic devices ,[PHYS.COND.CM-MS]Physics [physics]/Condensed Matter [cond-mat]/Materials Science [cond-mat.mtrl-sci] ,Materials chemistry ,Matematikk og Naturvitenskap: 400 [VDP] ,Article - Abstract
International audience; Silica (SiO2) is one of the most common materials on Earth. The crystalline form α-quartz is the stable silica polymorph at ambient conditions although metastable forms exist. α-quartz is a piezoelectric material, it can be produced artificially and is widely used for example in electronics and the biosciences. Despite the many application areas, the atomic surface structures of silica polymorphs are neither well understood nor well characterized. Here we present measurements of α-quartz (0001). Helium Atom Scattering combined with Atomic Force Microscopy reveals a giant reconstruction consisting of 5.55 ± 0.07 nm wide ribbons, oriented 10.4° ± 0.8° relative to the bulk unit cell. The ribbons, with the aid of atomistic modelling, can be explained as a self-organised pattern of nano Dauphine twins (nano electrical twins).
- Published
- 2015
- Full Text
- View/download PDF
17. Die Sinus- und Venenthrombose — eine Differenzialdiagnose des akuten Schlaganfalls
- Author
-
U. Dorenbeck, B. Holst, Wolfgang Reith, I. Q. Grunwald, Maria Politi, and Panagiotis Papanagiotou
- Subjects
Cerebral veins ,medicine.medical_specialty ,Vascular disease ,business.industry ,medicine.disease ,Thrombosis ,Venous thrombosis ,medicine.anatomical_structure ,Internal medicine ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,Differential diagnosis ,business ,Stroke ,Sinus (anatomy) ,Neuroradiology - Abstract
Thrombosis of the cerebral veins and sinus is a rare, but important cause of stroke. The clinical picture varies. This contribution addresses the etiology, clinical picture, imaging procedures, and therapeutic options.
- Published
- 2005
- Full Text
- View/download PDF
18. Differenzialdiagnose von Raumforderungen im Kleinhirnbr�ckenwinkel
- Author
-
Iris Q. Grunwald, B. Holst, G Brill, and Wolfgang Reith
- Subjects
Ependymoma ,business.industry ,Acoustic neuroma ,Anatomy ,Cerebellopontine angle ,medicine.disease ,Neuroma ,Cisterna ,Choroid plexus papilloma ,Facial nerve ,Paraganglioma ,otorhinolaryngologic diseases ,medicine ,Radiology, Nuclear Medicine and imaging ,business - Abstract
Most of the space demands in the cerebellopontine angle lie extra-axially. Important structures run within the cisterns of the cerebellopontine angle, such as the trigeminal, facial and vestibulocochlear nerves as well as the anterior inferior and posterior inferior cerebellar arteries and the veins which lead to the petrosal sinus. The most common space demands are caused by acoustic neuromas, meningeomas, vascular ectasia and aneurysms. Less common are epidermoid and other schwannomas as well as metastases, paragangliomas and arachnoidal cysts. Intra-axial tumours in the area of the cerebellopontine angle include the medulloblastoma, astrocytoma and the ependymoma, which occurs predominantly in children, in addition to the uncommon choroid plexus papilloma. Nearby, there are also space demands around the petrous bone, such as cholesterol granuloma, malignant otitis media, paraganglioma and metastases. For differential diagnosis, an understanding of the space requirements of the tumours in the cerebellopontine angle is needed in addition to knowledge of the anatomical structures.
- Published
- 2004
- Full Text
- View/download PDF
19. Klinik, Diagnostik und Therapie der Subarachnoidalblutung
- Author
-
B. Holst, I. Q. Grunwald, Wolfgang Reith, and V. Möller
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,Vascular disease ,business.industry ,medicine.medical_treatment ,Meningism ,Interventional radiology ,medicine.disease ,nervous system diseases ,Surgery ,Aneurysm ,Angiography ,Occlusion ,cardiovascular system ,medicine ,Radiology, Nuclear Medicine and imaging ,cardiovascular diseases ,Radiology ,Embolization ,medicine.symptom ,business ,Neuroradiology - Abstract
In most cases a saccular aneurysm is the cause of acute subarachnoidal hemorrhage (SAH). The usual symptoms are severe headache and meningism. Due to the high mortality rate caused by rebleeding an early occlusion of the aneurysm should be strived for. For this early diagnosis an exact identification of the aneurysm and its configuration is essential.
- Published
- 2002
- Full Text
- View/download PDF
20. Pentaisomaltose may act as an alternative to DMSO. Data from an engraftment study with cryopreserved human hematopoietic progenitor cells (HPCs) in immunodeficient NSG mice
- Author
-
B. Holst, E. Haastrup, L. Munthe-Fog, Mehrnaz Safaee Talkhoncheh, J.S. Gørløv, Jesper Dyrendom Svalgaard, Anne Fischer-Nielsen, C. Clausen, and Jonas Larsson
- Subjects
Cancer Research ,Transplantation ,Oncology ,Immunology ,Cancer research ,Immunology and Allergy ,Hematopoietic progenitor cells ,Cell Biology ,Biology ,Genetics (clinical) ,Cryopreservation - Published
- 2017
- Full Text
- View/download PDF
21. Lower versus higher hemoglobin threshold for transfusion in septic shock
- Author
-
Lars B, Holst, Nicolai, Haase, Jørn, Wetterslev, Jan, Wernerman, Anne B, Guttormsen, Sari, Karlsson, Pär I, Johansson, Anders, Aneman, Marianne L, Vang, Robert, Winding, Lars, Nebrich, Helle L, Nibro, Bodil S, Rasmussen, Johnny R M, Lauridsen, Jane S, Nielsen, Anders, Oldner, Ville, Pettilä, Maria B, Cronhjort, Lasse H, Andersen, Ulf G, Pedersen, Nanna, Reiter, Jørgen, Wiis, Jonathan O, White, Lene, Russell, Klaus J, Thornberg, Peter B, Hjortrup, Rasmus G, Müller, Morten H, Møller, Morten, Steensen, Inga, Tjäder, Kristina, Kilsand, Suzanne, Odeberg-Wernerman, Brit, Sjøbø, Helle, Bundgaard, Maria A, Thyø, David, Lodahl, Rikke, Mærkedahl, Carsten, Albeck, Dorte, Illum, Mary, Kruse, Per, Winkel, Anders, Perner, and J M, Breider
- Subjects
Male ,Risk ,medicine.medical_specialty ,Blood transfusion ,Randomization ,medicine.medical_treatment ,Myocardial Ischemia ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,law.invention ,03 medical and health sciences ,Hemoglobins ,0302 clinical medicine ,Randomized controlled trial ,Interquartile range ,law ,Ischemia ,medicine ,Humans ,Single-Blind Method ,Aged ,Septic shock ,business.industry ,030208 emergency & critical care medicine ,General Medicine ,Middle Aged ,medicine.disease ,Intensive care unit ,Shock, Septic ,3. Good health ,Surgery ,Intensive Care Units ,Anesthesia ,Relative risk ,Shock (circulatory) ,Female ,medicine.symptom ,business ,Erythrocyte Transfusion - Abstract
BACKGROUND: Blood transfusions are frequently given to patients with septic shock. However, the benefits and harms of different hemoglobin thresholds for transfusion have not been established.METHODS: In this multicenter, parallel-group trial, we randomly assigned patients in the intensive care unit (ICU) who had septic shock and a hemoglobin concentration of 9 g per deciliter or less to receive 1 unit of leukoreduced red cells when the hemoglobin level was 7 g per deciliter or less (lower threshold) or when the level was 9 g per deciliter or less (higher threshold) during the ICU stay. The primary outcome measure was death by 90 days after randomization.RESULTS: We analyzed data from 998 of 1005 patients (99.3%) who underwent randomization. The two intervention groups had similar baseline characteristics. In the ICU, the lower-threshold group received a median of 1 unit of blood (interquartile range, 0 to 3) and the higher-threshold group received a median of 4 units (interquartile range, 2 to 7). At 90 days after randomization, 216 of 502 patients (43.0%) assigned to the lower-threshold group, as compared with 223 of 496 (45.0%) assigned to the higher-threshold group, had died (relative risk, 0.94; 95% confidence interval, 0.78 to 1.09; P=0.44). The results were similar in analyses adjusted for risk factors at baseline and in analyses of the per-protocol populations. The numbers of patients who had ischemic events, who had severe adverse reactions, and who required life support were similar in the two intervention groups.CONCLUSIONS: Among patients with septic shock, mortality at 90 days and rates of ischemic events and use of life support were similar among those assigned to blood transfusion at a higher hemoglobin threshold and those assigned to blood transfusion at a lower threshold; the latter group received fewer transfusions. (Funded by the Danish Strategic Research Council and others; TRISS ClinicalTrials.gov number, NCT01485315.).
- Published
- 2014
- Full Text
- View/download PDF
22. In vivo incorporation of radioactive 36Cl, a method for monitoring chloro compounds in biological material
- Author
-
Kjeld C. Engvild, Pia B. Holst, and Carsten Christophersen
- Subjects
Radioisotopes ,Chromatography ,Chemistry ,Plant composition ,Organic Chemistry ,Brassica ,General Medicine ,Biochemistry ,Thin-layer chromatography ,Biological materials ,Analytical Chemistry ,In vivo ,Autoradiography ,Chlorine Compounds ,Analysis method - Abstract
A new method for fast and easy monitoring of the presence, isolation, and separation of natural chloro compounds in plants is described. The method relies on the in vivo incorporation of radioactive 36Cl and new enhancement methods in autoradiographic technology. The method allows the time of exposure to be limited to 4 days and is thus suitable for routine purposes.
- Published
- 2000
- Full Text
- View/download PDF
23. Helium reflectivity of the Si(111)-(1×1) H surface for use in atom optical elements
- Author
-
J.R. Buckland, William Allison, and B. Holst
- Subjects
Diffraction ,Surface (mathematics) ,Materials science ,Scattering ,Physics::Optics ,General Physics and Astronomy ,chemistry.chemical_element ,chemistry ,Atom ,Specular reflection ,Physical and Theoretical Chemistry ,Atomic physics ,Polar coordinate system ,Quantum ,Helium - Abstract
We investigate the reflectivity of Si(111)-(1×1) H for helium atoms with particular reference to atom optical applications, which require a high specular reflectivity. Quantum close-coupling calculations using an empirical potential are used to identify the optimum scattering conditions. We show that a diffraction probability >0.5 in the specular channel can be obtained in a kinematic window near 20 meV with near-normal incidence (polar angle
- Published
- 1999
- Full Text
- View/download PDF
24. Septischer Schock – Hb-Transfusionsgrenzwert bei septischem Schock
- Author
-
L B Holst
- Published
- 2015
- Full Text
- View/download PDF
25. Cyclisations of Tryptophans. IV. Cyclisation of Nb-Acyl-L-Tryptophanamides
- Author
-
Sine Larsen, Kurt V. Mikkelsen, Pia B. Holst, Ask Püschl, Carsten Christophersen, Alexander Senning, Per Halfdan Nielsen, and Uffe Anthoni
- Subjects
Chemistry ,Stereochemistry ,General Chemical Engineering - Published
- 1998
- Full Text
- View/download PDF
26. Red blood cell transfusion in septic shock - clinical characteristics and outcome of unselected patients in a prospective, multicentre cohort
- Author
-
Lars B. Holst, Morten H. Bestle, Anders Perner, Marte U Hagen, Peter Søe-Jensen, Nicolai Haase, Kristian Rørbæk Madsen, Ragnhild G Rosland, Morten Z Plambech, and Lone Musaeus Poulsen
- Subjects
Male ,medicine.medical_specialty ,Blood transfusion ,Anemia ,medicine.medical_treatment ,Critical Care and Intensive Care Medicine ,Sepsis ,Hemoglobins ,Risk Factors ,Intensive care ,Internal medicine ,Medicine ,Humans ,Prospective Studies ,Mortality ,Prospective cohort study ,APACHE ,Aged ,Original Research ,business.industry ,Septic shock ,hemic and immune systems ,Shock ,Middle Aged ,medicine.disease ,Shock, Septic ,Surgery ,Intensive Care Units ,Treatment Outcome ,Shock (circulatory) ,Cohort ,Emergency Medicine ,Female ,medicine.symptom ,business ,Erythrocyte Transfusion ,circulatory and respiratory physiology ,Follow-Up Studies - Abstract
BACKGROUND: Treating anaemia with red blood cell (RBC) transfusion is frequent, but controversial, in patients with septic shock. Therefore we assessed characteristics and outcome associated with RBC transfusion in this group of high risk patients.METHODS: We did a prospective cohort study at 7 general intensive care units (ICUs) including all adult patients with septic shock in a 5-month period.RESULTS: Ninety-five of the 213 included patients (45%) received median 3 (interquartile range 2-5) RBC units during shock. The median pre-transfusion haemoglobin level was 8.1 (7.4-8.9) g/dl and independent of shock day and bleeding. Patients with cardiovascular disease were transfused at higher haemoglobin levels. Transfused patients had higher Simplified Acute Physiology Score (SAPS) II (56 (45-69) vs. 48 (37-61), p = 0.0005), more bleeding episodes, lower haemoglobin levels days 1 to 5, higher Sepsis-related Organ Failure Assessment (SOFA) scores (days 1 and 5), more days in shock (5 (3-10) vs. 2 (2-4), p = 0.0001), more days in ICU (10 (4-19) vs. 4 (2-8), p = 0.0001) and higher 90-day mortality (66 vs. 43%, p = 0.001). The latter association was lost after adjustment for admission category and SAPS II and SOFA-score on day 1.CONCLUSIONS: The decision to transfuse patients with septic shock was likely affected by disease severity and bleeding, but haemoglobin level was the only measure that consistently differed between transfused and non-transfused patients.
- Published
- 2013
- Full Text
- View/download PDF
27. Modeling Formation Damage and Completion Geometry in an Old Well Enables Better Planning for New Wells - Gyda Development Case Study
- Author
-
E. Rojas, M. Byrne, and V. B. Holst
- Subjects
Engineering ,Engineering drawing ,Development (topology) ,Completion (oil and gas wells) ,business.industry ,business ,Productivity ,Construction engineering - Abstract
Gyda is a mature oil development in the Norwegian sector of the North Sea. The first production wells were drilled more than twenty years ago. This study focuses on wells drilled in the porer reservoir quality areas of the Gyda reservoir. Some recent production wells have significantly underperformed relative to equivalent initial wells. In particular, a sidetrack to an early successful well, had very poor performance on initial start-up. The geometry of the original well and the sidetrack were simulated, together with various assumptions and sensitivities to formation damage. In the original well an attempted hydraulic fracture had been assumed to have failed. This assumption was challenged in the model. The model demonstrated that the original well must have included a successful hydraulic fracture in order to flow at the historical rates recorded. In addition for the sidetrack, that contained no fracture, there were indications that the perforation tunnels may not have fully cleaned up and that whilst the well performance may recover somewhat with time, a significant change in completion would be required in order to match the performance of the original well. The model constructed included the completion geometry and formation damage and has enabled evaluation of old wells and more importantly, design of new wells in this mature reservoir development.
- Published
- 2013
- Full Text
- View/download PDF
28. Northwest-verging folds and the northwestward movement of the Caledonian Jotun Nappe, Norway
- Author
-
Haakon Fossen and Timothy B. Holst
- Subjects
Simple shear ,Décollement ,Crenulation ,Shear (geology) ,Geology ,Fold (geology) ,Slip (materials science) ,Petrology ,Shear band ,Seismology ,Nappe - Abstract
A family of asymmetric, northwest-verging back folds and crenulations occur on a regional scale in the Caledonian decollement zone in southwestern Norway. They are the result of reversal of the emplacement movement of the Jotun and other nappes in Early Devonian time. The back folds may have formed progressively by two different mechanisms: actively by buckling of the layering, and more passively by transfer of slip across the layering (reverse-slip crenulations) to balance the thinning of the zone caused by foliation-parallel slip and shear band formation. The former mechanism is considered to be most important during the initial stages of fold development, gradually giving way to the latter mechanism. The hinge lines of these folds appear to have remained stationary during deformation. This is explained by the observation that the hinge lines lie within or close to the shear plane, i.e. the plane of no rotation in simple shear deformation. Integration of strain across the deformation zone indicates a magnitude of back movement in the order of ca. 20–36 km, and it is argued that the deformation was close to simple shear.
- Published
- 1995
- Full Text
- View/download PDF
29. Isethionate in certain red algae
- Author
-
Pia B. Holst, S. E. Nielsen, Kirpal S. Bisht, V. S. Parmar, Uffe Anthoni, Dinabandhu Sahoo, Per Halfdan Nielsen, Sanjay Gupta, Amarjit Singh, and Carsten Christophersen
- Subjects
Chromatography ,biology ,Hypnaceae ,Plant physiology ,Isethionic acid ,Plant Science ,Red algae ,Aquatic Science ,biology.organism_classification ,Mass spectrometry ,chemistry.chemical_compound ,chemistry ,Algae ,Chemotaxonomy ,Botany ,Gigartinales - Abstract
Isethionic acid (2-hydroxyethanesulfonic acid) was isolated as salts from a methanolic extract ofHypnea musciformis collected in the Indian Ocean and identified by comparison (nuclear magnetic resonance, infrared and mass spectrometry) with an authentic sample. The compound has not previously been reported from plants. Investigations of 13 other species of red algae showed that only some samples of species of the families Gigartinaceae, Hypnaceae and Solieriaceae (all of order Gigartinales) contained isethionates.
- Published
- 1994
- Full Text
- View/download PDF
30. A Racemic Diterpene from the Marine Bryozoan Flustra foliacea, Natural Product or Artefact?
- Author
-
George W. Francis, Giovanni Sindona, Per Halfdan Nielsen, Tadashi Tokii, Dagfinn W. Aksnes, Klaus Bock, Uffe Anthoni, Pia B. Holst, and Carsten Christophersen
- Subjects
chemistry.chemical_compound ,Natural product ,chemistry ,biology ,Stereochemistry ,General Chemical Engineering ,Diterpene ,biology.organism_classification ,Flustra foliacea - Published
- 1994
- Full Text
- View/download PDF
31. Postcollisional cooling of the Penokean orogen in east-central Minnesota
- Author
-
Daniel R. Lux, Timothy B. Holst, and Daniel K. Holm
- Subjects
geography ,Plateau ,geography.geographical_feature_category ,Proterozoic ,Archean ,Geochemistry ,Orogeny ,engineering.material ,Basement (geology) ,Rhyolite ,engineering ,General Earth and Planetary Sciences ,Geology ,Gneiss ,Hornblende - Abstract
New 40Ar/39Ar thermochronologic data from the internal zone of the Penokean orogen in east-central Minnesota indicate rapid cooling from mid-crustal temperatures. Early Proterozoic metamorphosed cover rocks yield concordant hornblende and biotite plateau ages of ~ 1755 Ma. Underlying Archean basement gneiss yields concordant muscovite and biotite plateau ages of ~ 1705 Ma. These are some of the oldest cooling ages recorded in rocks buried during the 1830–1860 Ma Penokean collisional orogeny. Cooling was coeval with regional rhyolitic volcanism and granite emplacement, suggesting a period of tectonic activity in this region during mid to late 1700 Ma. Based on similarities with Phanerozoic extensional regimes, we suggest, preliminarily, that these data might be explained by a previously unrecognized major extensional episode in the Lake Superior region.
- Published
- 1993
- Full Text
- View/download PDF
32. Deformational History of Archean Metasedimentary Rocks of the Beartooth Mountains in the Vicinity of the Mineral Hill Mine, Jardine, Montana
- Author
-
Timothy B. Holst and Joseph D. Jablinski
- Subjects
geography ,Precambrian ,geography.geographical_feature_category ,Sill ,Metamorphic rock ,Archean ,Schist ,Geochemistry ,Geology ,Fold (geology) ,Mafic ,Petrogenesis - Abstract
Archean metasedimentary rocks of the South Snowy Block of the Beartooth Mountains, in the vicinity of Jardine, Montana, consist predominantly of schistose rocks (interpreted as metamorphosed turbidities) with rare iron formation. These rocks are intruded by Precambrian granitic stocks and minor mafic dikes and sills. Evidence for three phases of folding and late-stage kinking is found within the metasedimentary rocks, whereas rocks of the Crevice Mountain stock (2700 Ma) are unaffected by any of these events. The first folding event involved the development of isoclinal, recumbent folds of varying scale. F₁ fold hinges are rare, most commonly observed underground in Mineral Hill. An S₁ schistosity has developed axial planar to these folds. This schistosity, which is subparallel to bedding, is very well developed and ubiquitous in the metasedimentary rocks of the Jardine region. Large scale F₁ folds are inferred from the pattern of occurrence of iron formation within drill cores and because of the ubiquito...
- Published
- 1992
- Full Text
- View/download PDF
33. Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection
- Author
-
Eliana T. Nascimento, E.N. Miller, Priya Duggal, T.H. Beaty, Henio G. Lacerda, Mary E. Wilson, Richard W. Francis, A K B Holst, Selma M. B. Jeronimo, Sarra E. Jamieson, Gloria R. Monteiro, Jenefer M. Blackwell, Nicholas Ettinger, Daniella Regina Arantes Martins, Fabiana Lima Bezerra, and Heather J. Cordell
- Subjects
Male ,Linkage disequilibrium ,Genotype ,Immunology ,Single-nucleotide polymorphism ,Polymorphism, Single Nucleotide ,Article ,Genetics ,medicine ,Animals ,Humans ,Genetic Predisposition to Disease ,Hypersensitivity, Delayed ,Leishmania infantum ,Genetics (clinical) ,Alleles ,Immune response gene ,biology ,Computational Biology ,Leishmania chagasi ,medicine.disease ,biology.organism_classification ,Visceral leishmaniasis ,Logistic Models ,Phenotype ,Case-Control Studies ,Chromosomes, Human, Pair 5 ,Leishmaniasis, Visceral ,Female ,Sequence Alignment ,Brazil ,TGFBI - Abstract
Visceral leishmaniasis (VL) caused by Leishmania chagasi is endemic to northeast Brazil. A positive delayed-type hypersensitivity skin test response (DTH+) is a marker for acquired resistance to disease, clusters in families, and may be genetically controlled. Twenty-three single nucleotide polymorphisms (SNPs) were genotyped in the cytokine 5q23.3-q31.1 region IRF1-IL5-IL13-IL4-IL9-LECT2-TGFBI in 102 families (323 DTH+; 190 DTH−; 123 VL individuals) from a VL endemic region in northeast Brazil. Data from 20 SNPs were analysed for association with DTH+/− status and VL using family-based, stepwise conditional logistic regression analysis. Independent associations were observed between the DTH+ phenotype and markers in separate linkage disequilibrium blocks in LECT2 (OR 2.25; P=0.005; 95% CI=1.28-3.97) and TGFBI (OR 1.94; P=0.003; 95% CI=1.24-3.03). VL child/parent trios gave no evidence of linkage and association, but the DTH− phenotype was associated with SNP rs2070874 at IL4 (OR 3.14; P=0.006; 95% CI=1.38-7.14), and SNP rs30740 between LECT2 and TGFBI (OR 3.00; P=0.042; 95% CI=1.04-8.65). These results indicate several genes in the immune response gene cluster at 5q23.3-q31.1 influence outcomes of L. chagasi infection in this region of Brazil.
- Published
- 2007
34. Lebersche Hereditäre Opticusneuropathie (LHON) als Differentialdiagnose zur Retrobulbärneuritis: ein Fall einer LHON mit Schwellung des Chiasma opticum
- Author
-
A. Mühlpfordt, B. Holst, Michael Orth, Frank Leypoldt, Alexander Münchau, and C. Gerloff
- Subjects
Neurology (clinical) - Published
- 2007
- Full Text
- View/download PDF
35. Transfusionen im septischen Schock: Transfusionstrigger Hb-Schwellenwert
- Author
-
N Haase, Jørn Wetterslev, and L B Holst
- Abstract
Patienten im septischen Schock erhalten haufig Bluttransfusionen. Die Empfehlungen der Surviving Sepsis Campaign empfehlen Transfusionen mit dem Ziel, den Hamatokrit uber 30 % zu halten, und zwar fur die ersten 6 h. Ein Hamoglobinwert
- Published
- 2015
- Full Text
- View/download PDF
36. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis
- Author
-
Lars B. Holst, Anders Perner, Jørn Wetterslev, Marie Warrer Petersen, and Nicolai Haase
- Subjects
Relative risk reduction ,medicine.medical_specialty ,Models, Statistical ,business.industry ,General Medicine ,Odds ratio ,Lower risk ,Confidence interval ,Surgery ,Clinical trial ,Systematic review ,Meta-analysis ,Internal medicine ,Relative risk ,Odds Ratio ,medicine ,Humans ,Erythrocyte Transfusion ,business ,Randomized Controlled Trials as Topic - Abstract
Objective To compare the benefit and harm of restrictive versus liberal transfusion strategies to guide red blood cell transfusions. Design Systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Data sources Cochrane central register of controlled trials, SilverPlatter Medline (1950 to date), SilverPlatter Embase (1980 to date), and Science Citation Index Expanded (1900 to present). Reference lists of identified trials and other systematic reviews were assessed, and authors and experts in transfusion were contacted to identify additional trials. Trial selection Published and unpublished randomised clinical trials that evaluated a restrictive compared with a liberal transfusion strategy in adults or children, irrespective of language, blinding procedure, publication status, or sample size. Data extraction Two authors independently screened titles and abstracts of trials identified, and relevant trials were evaluated in full text for eligibility. Two reviewers then independently extracted data on methods, interventions, outcomes, and risk of bias from included trials. random effects models were used to estimate risk ratios and mean differences with 95% confidence intervals. Results 31 trials totalling 9813 randomised patients were included. The proportion of patients receiving red blood cells (relative risk 0.54, 95% confidence interval 0.47 to 0.63, 8923 patients, 24 trials) and the number of red blood cell units transfused (mean difference −1.43, 95% confidence interval −2.01 to −0.86) were lower with the restrictive compared with liberal transfusion strategies. Restrictive compared with liberal transfusion strategies were not associated with risk of death (0.86, 0.74 to 1.01, 5707 patients, nine lower risk of bias trials), overall morbidity (0.98, 0.85 to 1.12, 4517 patients, six lower risk of bias trials), or fatal or non-fatal myocardial infarction (1.28, 0.66 to 2.49, 4730 patients, seven lower risk of bias trials). Results were not affected by the inclusion of trials with unclear or high risk of bias. Using trial sequential analyses on mortality and myocardial infarction, the required information size was not reached, but a 15% relative risk reduction or increase in overall morbidity with restrictive transfusion strategies could be excluded. Conclusions Compared with liberal strategies, restrictive transfusion strategies were associated with a reduction in the number of red blood cell units transfused and number of patients being transfused, but mortality, overall morbidity, and myocardial infarction seemed to be unaltered. Restrictive transfusion strategies are safe in most clinical settings. Liberal transfusion strategies have not been shown to convey any benefit to patients. Trial registration PROSPERO CRD42013004272.
- Published
- 2015
- Full Text
- View/download PDF
37. Transfusionstrigger im septischen Schock: Ist niedriger besser?
- Author
-
L B Holst
- Published
- 2015
- Full Text
- View/download PDF
38. [Sinus and venous thrombosis--differential diagnosis of acute stroke]
- Author
-
I Q, Grunwald, M, Politi, B, Holst, U, Dorenbeck, P, Papanagiotou, and W, Reith
- Subjects
Diagnosis, Differential ,Stroke ,Venous Thrombosis ,Sinus Thrombosis, Intracranial ,Critical Care ,Acute Disease ,Practice Guidelines as Topic ,Humans ,Practice Patterns, Physicians' ,Cerebral Angiography - Abstract
Thrombosis of the cerebral veins and sinus is a rare, but important cause of stroke. The clinical picture varies. This contribution addresses the etiology, clinical picture, imaging procedures, and therapeutic options.
- Published
- 2005
39. [Differential diagnosis of space demands in the cerebellopontine angle]
- Author
-
B, Holst, I Q, Grunwald, G, Brill, and W, Reith
- Subjects
Cranial Nerves ,Cerebellopontine Angle ,Neuroma, Acoustic ,Syndrome ,Magnetic Resonance Imaging ,Sensitivity and Specificity ,Diagnosis, Differential ,Cerebrovascular Disorders ,Image Processing, Computer-Assisted ,Brain Stem Neoplasms ,Humans ,Cerebellar Neoplasms ,Tomography, X-Ray Computed ,Dilatation, Pathologic - Abstract
Most of the space demands in the cerebellopontine angle lie extra-axially. Important structures run within the cisterns of the cerebellopontine angle, such as the trigeminal, facial and vestibulocochlear nerves as well as the anterior inferior and posterior inferior cerebellar arteries and the veins which lead to the petrosal sinus. The most common space demands are caused by acoustic neuromas, meningeomas, vascular ectasia and aneurysms. Less common are epidermoid and other schwannomas as well as metastases, paragangliomas and arachnoidal cysts. Intra-axial tumours in the area of the cerebellopontine angle include the medulloblastoma, astrocytoma and the ependymoma, which occurs predominantly in children, in addition to the uncommon choroid plexus papilloma. Nearby, there are also space demands around the petrous bone, such as cholesterol granuloma, malignant otitis media, paraganglioma and metastases. For differential diagnosis, an understanding of the space requirements of the tumours in the cerebellopontine angle is needed in addition to knowledge of the anatomical structures.
- Published
- 2004
40. GLUCOSINOLATES
- Author
-
B. Holst and G.R. Fenwick
- Published
- 2003
- Full Text
- View/download PDF
41. Marine Alkaloids, 16. Reversible Conversion of Flustramine B N-1-Oxide to Flustrarine B
- Author
-
Per Halfdan Nielsen, Carsten Christophersen, Uffe Anthoni, and Pia B. Holst
- Subjects
Pharmacology ,Flustramine B ,chemistry.chemical_compound ,Complementary and alternative medicine ,Chemistry ,Organic Chemistry ,Drug Discovery ,Oxide ,Pharmaceutical Science ,Molecular Medicine ,Medicinal chemistry ,Analytical Chemistry - Published
- 1994
- Full Text
- View/download PDF
42. [Clinic, diagnosis, and therapy of subarachnoidal hemorrhage]
- Author
-
I Q, Grunwald, B, Holst, V, Möller, and W, Reith
- Subjects
Neurologic Examination ,Intracranial Embolism ,Angiography, Digital Subtraction ,Humans ,Subarachnoid Hemorrhage ,Tomography, X-Ray Computed ,Embolization, Therapeutic ,Magnetic Resonance Imaging ,Sensitivity and Specificity ,Magnetic Resonance Angiography ,Cerebral Angiography - Abstract
In most cases a saccular aneurysm is the cause of acute subarachnoidal hemorrhage (SAH). The usual symptoms are severe headache and meningism. Due to the high mortality rate caused by rebleeding an early occlusion of the aneurysm should be strived for. For this early diagnosis an exact identification of the aneurysm and its configuration is essential.
- Published
- 2002
43. New potential agents for cryopreservation of hematopoietic and adipose stromal cells
- Author
-
Anne Fischer-Nielsen, K. Theilgaard-Mönch, B. Holst, C. Clausen, K. Reckzeh, A. Brink, E. Haastrup, and Jesper Dyrendom Svalgaard
- Subjects
Cancer Research ,Transplantation ,Haematopoiesis ,Stromal cell ,Oncology ,Immunology ,Cancer research ,Immunology and Allergy ,Adipose tissue ,Cell Biology ,Biology ,Genetics (clinical) ,Cryopreservation - Published
- 2014
- Full Text
- View/download PDF
44. Focusing Helium Atom Beams Using Single Crystal Surfaces
- Author
-
W. Allison and B. Holst
- Subjects
Materials science ,Field (physics) ,Helium atom ,Scattering ,chemistry.chemical_element ,Atom probe ,Laser ,law.invention ,chemistry.chemical_compound ,chemistry ,law ,Moment (physics) ,Physics::Atomic and Molecular Clusters ,Physics::Atomic Physics ,Atomic physics ,Single crystal ,Helium - Abstract
The manipulation of molecular beams has a history dating back to the days of Stern and Gerlach [1]. In the last few years, new techniques have become available so that the field of atom-optics has now emerged, with several potential areas of application. Classical methods of manipulation, using inhomogeneous fields, as well as recent approaches, using laser manipulation, require atoms with accessible electronic states and/or a permanent moment; that is, atoms that are generally regarded as reactive. Inert atoms, such as helium, demand an alternative approach. The motivation for manipulating beams of helium atoms lies in their use as a tool in the study of surfaces. Inertness is the property that confers value as a surface probe since, at thermal energies, scattering from a surface occurs without reaction or surface damage. This short review discusses recent progress in focussing thermal beams of helium atoms, where the principal aim is to create a micro-focused atom probe.
- Published
- 2001
- Full Text
- View/download PDF
45. IEEE Std 4 'High voltage testing techniques': Past, present and future - IEEE/PES/PSIM High Voltage Testing Techniques Subcommittee Report
- Author
-
J. Rickmann, J. Kuffel, E. Hanique, R. Daharsh, Hugh Zhu, T.R. McComb, G. Fitzpatrick, R. Newnam, L. Wagenaar, L. Coffeen, J. McBride, S. Sebo, J. Hildreth, D. Train, D. Nichols, J. Kise, S. Tuli, Yicheng Wang, B. Holst, B. Ward, D. Dufield, B. Larzelere, H. Schneider, E. So, A. Molden, N. McQuin, D. Schweickart, M. Smith, R. Kremer, K. Loving, G. Schneider, Yixin Zhang, and J. Britton
- Subjects
Engineering ,Atmospheric measurements ,business.industry ,Electronic engineering ,Electrical engineering ,High voltage ,Iec standards ,business - Published
- 2001
- Full Text
- View/download PDF
46. Laryngeal oedema complicating extubation
- Author
-
S. Berry, R. Evans, B. Holst, and D. M. D. Evans
- Subjects
Anesthesiology and Pain Medicine ,Device removal ,business.industry ,medicine.medical_treatment ,Anesthesia ,medicine ,Intubation ,Airway obstruction ,Laryngeal oedema ,business ,Laryngeal Edema ,medicine.disease - Published
- 2007
- Full Text
- View/download PDF
47. Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial
- Author
-
Lars Nebrich, Jan-Michael Breider, Siv Leivdal, Nanna Reiter, Inga Tjäder, Anders Oldner, Jonathan White, Lars B. Holst, Gudmundur Klemenzson, Hans-Henrik Bülow, Jørgen Wiis, Anders Perner, Rasmus Broby Johansen, Jeanie M. Elkjær, Jørn Wetterslev, Omar Rian, Lasse H. Andersen, Susanne Iversen, Pär I. Johansson, Lone Musaeus Poulsen, Elsebeth Haunstrup, Helle Lykkeskov Nibro, Robert Winding, Per Martin Bådstøløkken, Kristian Strand, Sari Karlsson, Nicolai Haase, Ville Pettilä, Ulf Gøttrup, Carsten Albeck, Ditte Strange, Anders Aneman, Dorte Keld, Peter Roy Casparij Kirkegaard, Jørn-Åge Langva, Jan Wernerman, Niklas Nielsen, Pawel Berezowicz, Katrin Thormar, Asger Bendtsen, Matti Reinikainen, Anne Berit Guttormsen, Marianne L. Vang, Anne Lindhardt, Maria Cronhjort, Morten Steensen, and Jane S. Nielsen
- Subjects
Time Factors ,Iceland ,Medicine (miscellaneous) ,Red blood cell transfusion ,law.invention ,Study Protocol ,Hemoglobins ,0302 clinical medicine ,Fluid therapy ,Clinical Protocols ,law ,Risk Factors ,Septic shock ,Pharmacology (medical) ,030212 general & internal medicine ,hemic and immune systems ,Intensive care unit ,Shock, Septic ,3. Good health ,Intensive Care Units ,Treatment Outcome ,Research Design ,Shock (circulatory) ,Biological Markers ,Scandinavia ,medicine.symptom ,Clinical Trials Data Monitoring Committees ,Erythrocyte Transfusion ,circulatory and respiratory physiology ,medicine.medical_specialty ,Lung injury ,Scandinavian and Nordic Countries ,Risk Assessment ,Sepsis ,03 medical and health sciences ,Intensive care ,Multicenter trial ,medicine ,Humans ,Intensive care medicine ,business.industry ,030208 emergency & critical care medicine ,medicine.disease ,Clinical trial ,Emergency medicine ,business ,Biomarkers - Abstract
Transfusion of red blood cells (RBC) is recommended in septic shock and the majority of these patients receive RBC transfusion in the intensive care unit (ICU). However, benefit and harm of RBCs have not been established in this group of high-risk patients. The Transfusion Requirements in Septic Shock (TRISS) trial is a multicenter trial with assessor-blinded outcome assessment, randomising 1,000 patients with septic shock in 30 Scandinavian ICUs to receive transfusion with pre-storage leuko-depleted RBC suspended in saline-adenine-glucose and mannitol (SAGM) at haemoglobin level (Hb) of 7 g/dl or 9 g/dl, stratified by the presence of haematological malignancy and centre. The primary outcome measure is 90-day mortality. Secondary outcome measures are organ failure, ischaemic events, severe adverse reactions (SARs: anaphylactic reaction, acute haemolytic reaction and transfusion-related circulatory overload, and acute lung injury) and mortality at 28 days, 6 months and 1 year. The sample size will enable us to detect a 9% absolute difference in 90-day mortality assuming a 45% event rate with a type 1 error rate of 5% and power of 80%. An interim analysis will be performed after 500 patients, and the Data Monitoring and Safety Committee will recommend the trial be stopped if a group difference in 90-day mortality with P ≤0.001 is present at this point. The TRISS trial may bridge the gap between clinical practice and the lack of efficacy and safety data on RBC transfusion in septic shock patients. The effect of restrictive versus liberal RBC transfusion strategy on mortality, organ failure, ischaemic events and SARs will be evaluated. ClinicalTrials.gov: NCT01485315 . Registration date 30 November 2011. First patient was randomised 3 December 2011.
- Published
- 2013
- Full Text
- View/download PDF
48. Competition between folding and glycosylation in the endoplasmic reticulum
- Author
-
B, Holst, A W, Bruun, M C, Kielland-Brandt, and J R, Winther
- Subjects
Models, Molecular ,Protein Folding ,Binding Sites ,Glycosylation ,Base Sequence ,Molecular Sequence Data ,Cathepsin A ,Carboxypeptidases ,Saccharomyces cerevisiae ,Endoplasmic Reticulum ,Binding, Competitive ,carbohydrates (lipids) ,lipids (amino acids, peptides, and proteins) ,Amino Acid Sequence ,DNA, Fungal ,Research Article - Abstract
Using carboxypeptidase Y in Saccharomyces cerevisiae as a model system, the in vivo relationship between protein folding and N-glycosylation was studied. Seven new sites for N-glycosylation were introduced at positions buried in the folded protein structure. The level of glycosylation of such new acceptor sites was analysed by pulse-labelling under two sets of conditions that are known to reduce the rate of folding: (i) addition of dithiothreitol to the growth medium and (ii) introduction of deletions in the propeptide. A variety of effects was observed, depending on the position of the new acceptor sites. In some cases, all the newly synthesized mutant protein was modified at the novel site while in others no modification took place. In the most interesting category of mutants, the level of glycosylation was dependent on the conditions for folding. This shows that folding and glycosylation reactions can compete in vivo and that glycosylation does not necessarily precede folding. The approach described may be generally applicable for the analysis of protein folding in vivo.
- Published
- 1996
49. FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization
- Author
-
M, Schwartz, B, Holst, D, Facklam, and D, Buell
- Subjects
Graft Rejection ,Dose-Response Relationship, Drug ,Administration, Oral ,Humans ,Infusions, Intravenous ,Tacrolimus ,Liver Transplantation - Published
- 1995
50. A hollow-cathode plasma sputter source for production of metal cluster beams
- Author
-
J. Borggreen, B. Holst, E. Sondergard, Morten Nielsen, M. Krogh, H. D. Rasmussen, A. Xenoulis, Jakob Skou Pedersen, and Klavs Hansen
- Subjects
Diffraction ,Range (particle radiation) ,Materials science ,Physics::Instrumentation and Detectors ,Refractory metals ,Plasma ,Cathode ,law.invention ,Flow velocity ,Physics::Plasma Physics ,law ,Sputtering ,Cluster (physics) ,Atomic physics - Abstract
We have developed a source for the production of clusters of refractory metals by plasma sputtering. One aim is to produce metal clusters with a density of ~ 1012 atoms/cm3 in a size range of 102–105 atoms per cluster for the purpose of performing X-ray diffraction studies. Net sputtering rates have been measured for a Cu cathode, as a function of pressure, flow velocity, current, and cathode geometry. Computer simulations of the mass loss from the cathode reproduce the experimental results with reasonable agreement.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.